================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
X Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 for the fiscal year ended December 31, 2005
Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Commission File Number: 0-11453
AMERICAN PHYSICIANS SERVICE GROUP, INC.
(Exact name of registrant as specified in its charter)
Texas 75-1458323
(State or other jurisdiction of (I.R.S. employer Identification No.)
incorporation or organization)
1301 Capital of Texas Highway, Suite C-300,
Austin Texas 78746
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (512) 328-0888
Securities registered pursuant to Section 12(b) of the Act:
Name of each exchange
Title of each class on which registered
------------------- ---------------------
None None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.10 par value
(Title of Class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as
defined in Rule 405 of the Securities Act. Yes [ ] No [X]
Indicate by check mark if the registrant is not required to file reports
pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes |X| No |_|
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. |_|
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, or a non-accelerated filer. See definition of "accelerated
filer and large accelerated filer" in Rule 12b-2 of the Exchange Act.
(Check one):
Large accelerated filer |_| Accelerated filer |_| Non-accelerated filer |X|
Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Act). Yes |_| No |X|
State the aggregate market value of the voting and non-voting common equity held
by non-affiliates computed by reference to the price at which the common equity
was last sold, or the average bid and asked price of such common equity, as of
the last business day of the registrant's most recently completed second fiscal
quarter.
Aggregate Market Value at June 30, 2005: $26,245,118
Indicate the number of shares outstanding of each of the registrant's class
of common stock, as of the latest practicable date.
Number of Shares Outstanding At
Title of Each Class March 1, 2006
------------------- ---------------
Common Stock, $.10 par value 2,750,664
Documents Incorporated By Reference
Selected portions of the Registrant's definitive proxy material for the
2006 annual meeting of shareholders are incorporated by reference into
Part III of the Form 10-K.
TABLE OF CONTENTS
PAGE
PART I
Item 1. Business 3
Item 1A. Risk Factors 10
Item 2. Properties 15
Item 3. Legal Proceedings 15
Item 4. Submission of Matters to a Vote of Security Holders 15
PART II
Item 5. Market for Registrant's Common Equity and Related
Stockholder Matters 15
Item 6. Selected Financial Data 17
Item 7. Management's Discussion and Analysis of Financial Condition
and Results of Operations 18
Item 7A. Quantitative and Qualitative Disclosures about Market Risk 29
Item 8. Financial Statements and Supplementary Data 30
Item 9. Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure 31
Item 9A. Controls and Procedures 31
Item 9B. Other Information 31
PART III
Item 10. Directors and Executive Officers of the Registrant 31
Item 11. Executive Compensation 32
Item 12. Security Ownership of Certain Beneficial Owners and
Management and Related Stockholder Matters 32
Item 13. Certain Relationships and Related Transactions 32
Item 14. Principal Accountant Fees and Services 32
PART IV
Item 15. Exhibits and Financial Statement Schedules 32
SIGNATURES 36
EXHIBIT INDEX A-1
EX-21.1 (Subsidiaries of the Registrant)
EX-23.1 (Consents of Experts and Counsel)
EX-31.1 (Certification of Chief Executive Officer)
EX-31.2 (Certification of Chief Financial Officer)
EX-32.1 (Certification of Chief Executive Officer)
EX-32.2 (Certification of Chief Financial Officer)
2
AMERICAN PHYSICIANS SERVICE GROUP, INC.
ANNUAL REPORT ON FORM 10-K
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2005
References in this report to "we", "us", "our", and the "Company" mean American
Physicians Service Group, Inc.
PART I
ITEM 1. BUSINESS
GENERAL
We, through our subsidiaries, provide services that include brokerage and
investment services to individuals and institutions, and management and agency
services to malpractice insurance companies.
We were organized in October 1974 under the laws of the State of Texas. Our
principal executive office is at 1301 Capital of Texas Highway, Suite C-300,
Austin, Texas 78746, and our telephone number is (512) 328-0888. Our website is
www.amph.com. We make available free of charge on our website our Annual Report
on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
any amendments to those reports filed or furnished pursuant to Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act,
as soon as reasonably practicable after such material is electronically filed
with, or furnished to, the Securities and Exchange Commission, or the SEC.
Financial information about our industry segments is disclosed in Note 16
to our accompanying consolidated financial statements in Appendix A hereof.
OUR FINANCIAL SERVICES
Through our subsidiaries, APS Financial Corporation, or APS Financial, APS
Clearing, Inc., or APS Clearing, and APS Asset Management, Inc., or Asset
Management, we provide investment and investment advisory services to
institutions and individuals throughout the United States. Our revenues from
this segment were 54%, 52% and 64% of our total revenues in 2005, 2004 and 2003,
respectively.
APS Financial is a fully licensed broker/dealer that provides brokerage and
investment services primarily to institutional and high net worth individual
clients. APS Financial also provides portfolio accounting, analysis, and other
services, to insurance companies, banks, and public funds. APS Financial has its
main office in Austin, Texas with a branch office in Houston, Texas.
APS Financial charges commissions on both exchange and over-the-counter, or
OTC, transactions in accordance with industry practice. When APS Financial
executes OTC transactions as a dealer, it receives, in lieu of commissions,
markups or markdowns.
APS Financial is a member of the National Association of Securities
Dealers, Inc., or NASD, and the Securities Investor Protection Corporation, or
SIPC, and, in addition, is licensed in 44 states and Washington D.C.
Every registered broker/dealer doing business with the public is subject to
stringent rules with respect to net capital requirements promulgated by the SEC.
These rules, which are designed to measure the financial soundness and liquidity
of broker/dealers, specify minimum net capital requirements. As a registered
broker/dealer, APS Financial is subject to these rules. Compliance with
applicable net capital requirements could limit APS Financial's operations, such
3
as limiting or prohibiting trading activities that require the use of
significant amounts of capital. A significant operating loss or an extraordinary
charge against net capital could adversely affect the ability of APS Financial
to expand or even maintain its present levels of business. At December 31, 2005,
APS Financial was in compliance with all applicable net capital requirements.
APS Financial clears its transactions through Southwest Securities, Inc.,
or Southwest, on a fully disclosed basis. Southwest also processes orders and
floor reports, matches trades, transmits execution reports to APS Financial and
records all data pertinent to trades. APS Financial pays Southwest a fee based
on the number and type of transactions that Southwest conducts for APS
Financial.
APS Clearing was established in 2005 and is dedicated to the clearing and
settlement of trades involving syndicated bank loans, trade claims and
distressed private loan portfolios. This company seeks to develop business with
clients who trade in the high-yield bond market. In addition, to marketing to
professional hedge funds and institutional clientele, we also may receive
referral leads from our affiliate companies.
Asset Management, a registered investment adviser under the Investment
Advisers Act of 1940, was formed and registered with the SEC in 1998. We formed
Asset Management to manage fixed income and equity assets for institutional and
individual clients on a fee basis. Asset Management's mission is to provide
clients with investment results within specific client-determined risk
parameters.
OUR INSURANCE SERVICES
APS Insurance Services, Inc., or Insurance Services, is our wholly-owned
subsidiary. Prior to October 1, 2003, we owned 80% of Insurance Services. On
October 1, 2003, we acquired the remaining 20% minority interest in Insurance
Services for approximately $2.0 million in cash (see Note 14 to our consolidated
financial statements included herein). Insurance Services, through its
wholly-owned subsidiaries APS Facilities Management, Inc., dba APMC Insurance
Services, Inc., or FMI, and American Physicians Insurance Agency, Inc., or
Agency, provides management and agency services to medical malpractice insurance
companies. Our revenues from this segment contributed 46%, 48% and 36% of our
total revenues in 2005, 2004 and 2003, respectively.
Substantially all of our revenue from the insurance services segment was
attributable to FMI providing management services to American Physicians
Insurance Exchange, or APIE, a reciprocal insurance exchange, wholly-owned by
its subscriber physicians. A reciprocal insurance exchange is an organization
that sells insurance only to its subscribers, who pay, in addition to their
annual insurance premiums, a contribution to the exchange's surplus. These
exchanges generally have no paid employees and, instead, enter into a contract
with an "attorney-in-fact" that provides all management and administrative
services for the exchange. As the attorney-in-fact for APIE, FMI receives a
percentage of the earned premiums of APIE, as well as a portion of APIE's
profits. The amount of these premiums can be adversely affected by competition.
Substantial underwriting losses, which might result in a curtailment or
cessation of operations by APIE, would also adversely affect FMI's revenue and,
accordingly, our revenue. To limit possible underwriting losses, APIE currently
reinsures its risk in excess of $250,000 per medical incident. APIE offers
medical professional liability insurance for physicians in Texas and Arkansas.
FMI's assets are not subject to any insurance claims by policyholders of APIE.
FMI has been APIE's exclusive manager since APIE's inception in 1975. The
management agreement between FMI and APIE provides for full management by FMI of
the affairs of APIE under the direction of APIE's physician board of directors.
Subject to the direction of this board, FMI sells and issues policies,
investigates, settles and defends claims, and otherwise manages APIE's affairs.
As described below, in consideration for performing its services, FMI receives a
management fee based on APIE's earned premiums (before payment of reinsurance
premiums), as well as a portion of APIE's profits. FMI pays salaries and
personnel related expenses, rent and office operations costs, information
technology costs and many other operating expenses of APIE. APIE is responsible
for the payment of all claims, claims expenses, peer review expenses, directors'
4
fees and expenses, legal, actuarial and auditing expenses, its taxes, outside
agent commissions and certain other specific expenses. Under the management
agreement, FMI's authority to act as manager of APIE is automatically renewed
each year unless a majority of the subscribers to APIE elect to terminate the
management agreement by reason of an adjudication that FMI has been grossly
negligent, has acted in bad faith or with fraudulent intent or has committed
willful misfeasance in its management activities. Termination of FMI's
management agreement with APIE would have a material adverse effect on us.
APIE is authorized to do business in the States of Texas and Arkansas, and
specializes in writing medical professional liability insurance for healthcare
providers. It writes insurance in Texas primarily through purchasing groups and
is not subject to certain rate and policy form regulations issued by the Texas
Department of Insurance. It reviews applicants for insurance coverage based on
the nature of their practices, prior claims records and other underwriting
criteria. APIE is one of the largest medical professional liability insurance
companies in the State of Texas. APIE is the only professional liability
insurance company based in Texas that is wholly-owned by its subscriber
physicians.
Generally, medical professional liability insurance is offered on either a
"claims made" basis or an "occurrence" basis. "Claims made" policies insure
physicians only against claims that occur and that are reported during the
period covered by the policy. "Occurrence" policies insure physicians against
claims based on occurrences during the policy period regardless of when they are
reported. APIE offers only a "claims made" policy in Texas and Arkansas, but
provides for an extended reporting option upon termination of the policy. APIE
reinsures 100% of all Texas and Arkansas coverage risk between $250,000 and
$1,000,000 per medical incident, primarily through certain domestic and
international insurance companies.
The management agreement with FMI obligates APIE to pay management fees to
FMI based on APIE's earned premiums before payment of reinsurance premiums. The
management fee percentage is 13.5% with the provision that any profits of APIE
will be shared equally with FMI so long as the total payment (fees and profit
sharing) does not exceed a cap based on premium levels. While APIE was
profitable in 2001 and 2002 there was no profit sharing with FMI due to the
management agreement requiring that prior year losses be applied against future
pre-tax income. Only after prior year losses are completely offset can FMI then
share equally the profits at APIE.
The following table presents selected financial and other data for APIE:
Years Ended December 31,
-------------------------------------------------------------------
2005 2004 2003 2002 2001
---- ---- ---- ---- ----
(Unaudited, in thousand, except for number of insureds)
Earned premiums before reinsurance premiums $ 66,899 $ 64,296 $ 51,904 $ 46,078 $ 35,866
Total assets 145,128 131,152 102,728 80,721 64,557
Total surplus 29,789 21,238 15,783 12,985 11,475
Management fees (including commissions)(1) 9,031 8,675 7,067 6,221 5,084
Profit sharing 2,007 1,929 722 -- --
Number of insureds 3,923 3,623 3,073 3,181 3,101
(1) This amount includes management fees and commissions paid to FMI
and Agency in addition to commissions of $0, $1, $513, $3,103, and
$2,886 in 2005, 2004, 2003, 2002 and 2001, respectively, paid to
other carriers directly related to APIE's controlled business.
5
OUR OTHER INVESTMENTS
At December 31, 2005, we owned less than 1% of the outstanding common stock
of HealthTronics, Inc, or HealthTronics (successor by merger to Prime Medical
Services, Inc.) having reduced our ownership from 15% with the sale of 1,591,000
shares during 2002. Prior to that sale we recorded our pro-rata shares of
HealthTronics' earnings using the equity method of accounting. As a result of
our reduced ownership, we now account for our investment as an
available-for-sale equity security, with changes in market value, net of tax,
reflected in shareholders' equity as "accumulated other comprehensive income."
At December 31, 2005, our investment in HealthTronics common stock has an
aggregate fair market value of $1,095,000 and a cost basis of approximately
$719,000. A material decline in the value of this investment could have a
material adverse effect on our results of operations.
The common stock of HealthTronics is quoted on the NASDAQ National Market
under the symbol "HTRN." HealthTronics is a Georgia corporation and is required
to file annual, quarterly and other reports and documents with the SEC. The
summary information in the accompanying consolidated financial statements
regarding HealthTronics is qualified in its entirety by reference to such
reports and documents. Such reports and documents may be examined and copies may
be obtained from the SEC.
In June 2003, we purchased from Financial Industries Corporation ("FIC")
(OTC:FNIN.PK) and the Roy F. and Joann Cole Mitte Foundation 339,879 shares of
FIC's common stock as an investment. Earlier in 2003, we had purchased 45,121
FIC shares in the open market. The 385,000 shares represent an approximate 4%
ownership in FIC. The aggregate purchase price was approximately $5,647,000,
which was all sourced from our cash reserves. The shares purchased from FIC and
the foundation are not registered, but are subject to a registration rights
agreement requiring FIC's best efforts to register them within one year of the
transaction. Due to FIC's delay in filing its 2003 Form 10-K and its subsequent
10-Q's, it has not been able to register these shares and was delisted from the
NASDAQ exchange in July 2004.
During 2004, the value of our investment in FIC had declined significantly.
In October 2004, we determined that this decline in market price should be
considered "other than temporary" as defined in Statements of Financial
Accounting Standards (SFAS) No. 115, Accounting for Certain Investments in Debt
and Equity Securities, as amended. Consequently, we recorded pre-tax charges to
earnings totaling $2,567,000 in 2004. These charges reduced our cost basis in
FIC from $5,647,000, or $14.67 per share, to $3,080,000, or $8.00 per share,
which was equal to the quoted market price of FIC shares on December 31, 2004.
During 2005, we took additional pre-tax charges to earnings totaling $135,000,
further reducing our cost basis in FIC to $2,945,000, or $7.65 per share. While
we currently continue to have the ability and the intent to hold the stock
indefinitely, we concluded that the additional uncertainty created by FIC's late
filings, together with the lack of its current financial information, dictated
that the 2004 and 2005 declines should be viewed as other than temporary. In
July 2005, FIC was able to file its 2003 Form 10-K but has yet to file any 2004
or 2005 Forms 10-Q or 10-K and thus continues to be de-listed on the NASDAQ
Stock Market. We will continue to monitor and evaluate the situation at FIC and
further determine if changes in fair market value of the investment are
temporary or "other than temporary."
FIC is a Texas corporation and is required to file annual, quarterly and
other reports and documents with the SEC. (The summary information in the
accompanying consolidated financial statements regarding FIC is qualified in its
entirety by reference to such reports and documents.) Such reports and
documents, prior to January 1, 2004, may be obtained from the SEC.
In April 2004, we purchased $300,000 of Toys R Us bonds. In March 2005,
Toys R Us announced a plan of merger with another toy company and a planned
leveraged buyout, which precipitated a drop in the price of the bonds. An
independent analysis indicated that the new debt to be issued in connection with
the leveraged buyout will put the existing bonds in a subordinated position.
Since these bonds have a 2018 maturity, we believe that the impairment is "other
than temporary" during our shorter than expected holding period. Consequently,
6
we wrote a charge against pre-tax earnings of $57,000 using the quoted price of
the bonds as of June 30, 2005.
By December 2005, the value of the bonds had declined further and, based in
part upon weak earnings reports, we determined that an additional impairment
charge of $24,000 was necessary using the quoted price of the bonds as of
December 31, 2005. We will continue to monitor and evaluate the situation at
Toys R Us and further determine if changes in fair market value of the
investment are temporary or "other than temporary."
DISCONTINUED OPERATIONS
Effective November 1, 2002, we sold APS Consulting to its management as we
determined the division's operations were not consistent with our long-term
strategic plan. We sold all of our APS Consulting shares for a de minimus amount
of cash plus a $250,000 seven-year term note at the prime rate plus 3%. Our
existing contract, which was entered into on October 1, 2002, and states that we
will provide administrative support services to APS Consulting for a period of
approximately seven years, remains in effect. The fees that we will receive
under this contract are dependent on APS Consulting's pre-tax earnings, but may
not be less than $200,000 or more than $518,000 over the life of the agreement.
Because we were dependent upon the future successful operation of APS Consulting
to collect our proceeds from the disposal and because we had a security interest
in the assets of APS Consulting, our retained risk of loss precluded us from
recognizing the divestiture of APS Consulting under the guidance of FASB
Interpretation No 46. Accordingly, we did not recognize the divestiture of APS
Consulting and continued to consolidate the division as an entity in which we
had a variable interest that would absorb the majority of the entity's operating
losses if they occurred.
Effective November 1, 2003, APS Consulting was able to obtain third party
financing and repay their note payable to us in exchange for our agreeing to
discount the note by $35,000. We provided no guarantees or credit enhancements
in connection with APS Consulting securing this financing. Accordingly, we no
longer have a risk of loss related to these operations and have recognized the
transaction as a divestiture. As a result, we ceased consolidation of APS
Consulting financial statements effective November 1, 2003. In addition, we were
able to recognize a gain in 2003 of $27,000, net of tax, and administrative
support fees totaling $103,000 in 2005, $47,000 in 2004 and $98,000 in 2003.
COMPETITION
FINANCIAL SERVICES
APS Financial and Asset Management are engaged in a highly competitive
business. Their competitors include, with respect to one or more aspects of
their business, all of the member organizations of the New York Stock Exchange
and other registered securities exchanges, all members of the NASD, registered
investment advisors, members of the various commodity exchanges and commercial
banks and thrift institutions. Many of these organizations are national rather
than regional firms and have substantially greater personnel and financial
resources than us. In many instances APS Financial is competing directly with
these organizations. In addition, there is competition for investment funds from
the real estate, insurance, banking and thrift industries.
INSURANCE SERVICES
Substantially all of our revenue from this segment was attributable to FMI
providing management services to APIE. Because FMI's management fee is based on
the earned premiums of APIE and APIE's profits, our revenue can be adversely
affected by APIE's competition. While there is not direct competition with
respect to providing management services to medical malpractice insurance
companies, APIE does compete with several insurance carriers, including Medical
Protective Insurance Company, Texas Medical Liability Trust, ProAssurance, The
Doctors Company, Advocate MD and the Texas Medical Liability Insurance
Underwriting Association (JUA), which is the state-sponsored insurer of last
resort. APIE does not have the capacity to write the volume of business equal to
that of the other carriers. Great focus has been given to the area of
underwriting and the selection of insured physicians. With the successful
passing of tort reform in late 2003, there is an increased likelihood of
additional companies re-entering the Texas market.
7
REGULATION
FINANCIAL SERVICES
APS Financial and Asset Management are subject to extensive regulation
under both federal and state laws. The SEC is the federal agency charged with
administration of the federal securities and investment advisor laws. Much of
the regulation of broker/dealers, however, has been delegated to self-regulatory
organizations, principally the NASD and the national securities exchanges. These
self-regulatory organizations adopt rules (subject to approval by the SEC) which
govern the industry and conduct periodic examinations of member broker/dealers.
APS Financial is also subject to regulation by state and District of Columbia
securities commissions.
The regulations to which APS Financial is subject cover all aspects of the
securities business, including sales methods, trade practices among
broker/dealers, uses and safekeeping of customers' funds and securities, capital
structure of securities firms, record keeping and the conduct of directors,
officers and employees. Additional legislation, changes in rules promulgated by
the SEC and by self-regulatory organizations, or changes in the interpretation
or enforcement of existing laws and rules, may directly affect the method of
operation and profitability of APS Financial and, accordingly, us. The SEC,
self-regulatory organizations and state securities commissions may conduct
administrative proceedings that can result in censure, fine, suspension or
expulsion of APS Financial, its officers or employees. The principal purpose of
regulation and discipline of broker/dealers is the protection of customers and
the securities markets, rather than protection of creditors and shareholders of
broker/dealers.
APS Financial, as a registered broker/dealer and NASD member organization,
is required by federal law to belong to the SIPC. When the SIPC fund falls below
a certain minimum amount, members are required to pay annual assessments in
varying amounts not to exceed .5% of their adjusted gross revenues to restore
the fund. The SIPC fund provides protection for customer accounts up to $500,000
per customer, with a limitation of $100,000 on claims for cash balances.
INSURANCE SERVICES
FMI has received certificates of authority from the Texas and Arkansas
insurance departments, licensing it on behalf of the subscribers of APIE. APIE,
as an insurance company, is subject to regulation by the insurance departments
of the States of Texas and Arkansas. These regulations strictly limit all
financial dealings of a reciprocal insurance exchange with its officers,
directors, affiliates and subsidiaries. In the case of APIE, these regulations
apply to FMI. Premium rates, advertising, solicitation of insurance, types of
insurance issued and general corporate activity are also subject to regulation
by various state agencies.
REVENUES AND INDUSTRY SEGMENTS
The information required by Regulation S-K Items 101(b) and 101(d) related
to financial information about segments and financial information about sales is
contained in Note 16 of our consolidated financial statements included in
Appendix A of this Form 10-K.
EMPLOYEES
At March 1, 2006, we employed, on a full time basis, approximately 112
persons, including 58 by Insurance Services, 46 by APS Financial and APS
Clearing, and 8 directly by us. We consider our employee relations to be good.
None of our employees are represented by a labor union and we have experienced
no work stoppages.
8
EXECUTIVE OFFICERS
As of March 1, 2006, our executive officers were as follows:
Name Age Position
---- ---- ----------
Kenneth S. Shifrin 56 Chairman of the Board, President and
Chief Executive Officer
William H. Hayes 58 Senior Vice President -Finance,
Secretary, and Chief Financial
Officer
Maury L. Magids 41 Senior Vice President - Insurance
Thomas R. Solimine 47 Controller
Our officers serve until the next annual meeting of our directors and until
their successors are elected and qualified (or until their earlier death,
resignation or removal).
Mr. Shifrin has been our Chairman of the Board since March 1990. He has
been our President and Chief Executive Officer since March 1989 and he was
President and Chief Operating Officer from June 1987 to February 1989. He has
been a director since February 1987. From February 1985 until June 1987, Mr.
Shifrin served as our Senior Vice President - Finance and Treasurer. Mr. Shifrin
also has been a director of Financial Industries Corporation since June 2003 and
was Chairman of the Board of Prime Medical Services, Inc. from October 1989
until November 2004. With the merger of Prime Medical and HealthTronics, Mr.
Shifrin became Vice-chairman of the Board of HealthTronics in November 2004. Mr.
Shifrin is a member of the World Presidents Organization.
Mr. Hayes has been our Senior Vice President - Finance since June 1995. Mr.
Hayes was our Vice President from June 1988 to June 1995 and was our Controller
from June 1985 to June 1987. He has been our Secretary since February 1987 and
our Chief Financial Officer since June 1987. Mr. Hayes is a Certified Public
Accountant.
Mr. Magids has been our Senior Vice President - Insurance Services since
June 2001 and has been President and Chief Operating Officer of FMI since
November 1998. Mr. Magids joined us in October 1996. Mr. Magids is a Certified
Public Accountant and was with Arthur Andersen LLP from August 1986 until
September 1996, most recently as Director of Business Development.
Mr. Solimine has been our Controller since June 1994. He has served as
Secretary for APS Financial since February 1995. From July 1989 to June 1994,
Mr. Solimine served as our Manager of Accounting.
There are no family relationships, as defined, among any of our executive
officers, and there is no arrangement or understanding between any of our
executive officers and any other person pursuant to which he or she was selected
as an officer. Each of our executive officers was elected by our board of
directors to hold office until the next annual election of officers and until
his or her successor is elected and qualified or until his or her earlier death,
resignation or removal. Our board of directors elects our officers in
conjunction with each annual meeting of our shareholders.
AVAILABLE INFORMATION
We file annual, quarterly, and current reports, proxy statements, and other
documents with the SEC under the Exchange Act. You may read and copy any
materials that we file with the SEC at the SEC's public reference room at 450
Fifth Street, NW, Washington, DC 20549. The public may obtain information on the
operation of the public reference room by calling the SEC at 1-800-SEC-0330.
Also, the SEC maintains a website that contains these SEC filings. You can
obtain these filings at the SEC's website at http://www.sec.gov.
9
We also make available free of charge on or through our website
(http://www.amph.com) our Annual Report on Form 10-K, Quarterly Reports on Form
10-Q, Current Reports on Form 8-K, and, if applicable, amendments to those
reports filed or furnished pursuant to Section 13(a) of the Exchange Act as soon
as reasonably practicable after we electronically file such material with, or
furnish it to, the SEC.
ITEM 1A. RISK FACTORS
An investment in our common stock involves certain risks. Below are the
most significant factors that make an investment in us speculative or risky. You
should consider carefully these risks together with all of the other information
included in this Form 10-K and the documents that we have incorporated by
reference.
APPROXIMATELY ONE-HALF OF OUR REVENUE FROM CONTINUING OPERATIONS IS
ATTRIBUTABLE TO OUR MANAGEMENT AGREEMENT WITH APIE, PURSUANT TO WHICH WE RECEIVE
FEES BASED ON APIE'S SUCCESS AND ARE REQUIRED TO PROVIDE CERTAIN SERVICES AT OUR
COST.
Substantially all of our revenue from the insurance services segment,
representing 46% of total revenue in 2005, was attributable to FMI providing
management services to APIE. As the attorney-in-fact for APIE, FMI receives a
percentage of the earned premiums of APIE, as well as a portion of APIE's
profits. Accordingly, any reduction in premiums written by APIE or profit
recorded by APIE would have a proportional negative effect on our revenues and
net income. The amount of these premiums can be adversely affected by
competition. Substantial underwriting losses, which might result in a
curtailment or cessation of operations by APIE, would also adversely affect
FMI's revenue and, accordingly, our revenue. The loss or reduction of these
management fees could have a material adverse effect on our business, financial
condition and results of operations.
Pursuant to our management agreement with APIE, FMI is required to perform
a number of sales, underwriting and management and administrative services at
the direction of the Board of APIE associated with the issuance of insurance
policies for APIE to earn FMI's management fee, regardless of the cost to FMI of
providing those services. We could lose money or be less profitable if our cost
of providing those services increases significantly.
OUR SUBSIDIARIES OPERATE IN HIGHLY COMPETITIVE BUSINESSES AGAINST
COMPETITORS WITH GREATER FINANCIAL, MARKETING, TECHNOLOGICAL, PERSONNEL AND
OTHER RESOURCES.
The industries in which we operate are highly competitive. Many of our
competitors possess greater financial, marketing, technological and other
resources. There can be no assurance that we will be able to continue to compete
successfully.
APS Financial, Asset Management and APS Clearing are engaged in a highly
competitive business. Their competitors include, with respect to one or more
aspects of their business, all of the member organizations of the New York Stock
Exchange and other registered securities exchanges, all members of the NASD,
registered investment advisors, members of the various commodity exchanges and
commercial banks and thrift institutions. In many instances APS Financial is
competing directly with these organizations. In addition, there is competition
for investment funds from the real estate, insurance, banking and thrift
industries.
As stated above, substantially all of our revenue from the insurance
services segment was attributable to FMI providing management services to APIE.
Because FMI's management fee is based on the earned premiums of APIE and APIE's
profits, our revenue can be adversely affected by APIE's competition. APIE
competes with several insurance carriers, including Medical Protective Insurance
Company, Texas Medical Liability Trust, ProAssurance, The Doctors Company,
Advocate MD and the Texas Medical Liability Insurance Underwriting Association
(JUA), which is the state-sponsored insurer of last resort. APIE does not have
the capacity to write the volume of business equal to that of the other major
carriers. With the successful passing of tort reform in late 2003, there is an
increased likelihood of additional companies re-entering the Texas market.
10
AS A HOLDING COMPANY, OUR FINANCIAL CONDITION AND RESULTS OF OPERATIONS ARE
DEPENDENT ON OUR SUBSIDIARIES.
We are principally a holding company with assets consisting primarily of
cash and investment securities. Consequently, our ability to pay our operating
expenses and to service our indebtedness is dependent upon the earnings of our
subsidiaries and our ability to receive funds from such subsidiaries through
loans, dividends or otherwise. The subsidiaries are legally distinct entities
and have no obligation, contingent or otherwise, to make funds available to us
for such obligations. In addition, our subsidiaries' ability to make such
payments is subject to applicable state laws, and claims of our subsidiaries'
creditors will generally have priority as to the assets of such subsidiaries.
Accordingly, there can be no assurance that our subsidiaries will be able to pay
funds to us or that such funds, if any, received by us will be sufficient to
enable us to meet our obligations.
OUR FINANCIAL SERVICES BUSINESS IS SUBJECT TO EXTENSIVE GOVERNMENT
REGULATION.
The securities industry is subject to extensive governmental supervision,
regulation and control by the SEC, state securities commissions and
self-regulatory organizations, which may conduct administrative proceedings that
can result in censure, fine, suspension or expulsion of APS Financial or any of
its officers or employees. The NASD regulates our financial services business'
marketing activities. The NASD can impose certain penalties for violations of
its advertising regulations, including censures or fines, suspension of all
advertising, the issuance of cease-and-desist orders or the suspension or
expulsion of a broker-dealer or any of its officers or employees.
Our ability to comply with all applicable laws and rules is largely
dependent on our establishment and maintenance of a system to ensure compliance
with these laws and rules, as well as our ability to attract and retain
qualified compliance personnel. We could be subject to disciplinary or other
actions due to claimed noncompliance in the future, which could have a material
adverse effect on our business, financial condition and operating results.
There can be no assurance that the federal or state governments or
self-regulatory organizations having jurisdiction over our insurance and
securities brokerage businesses will not adopt regulations or take other
actions, such as the failure to renew or the revocation of required licenses and
certifications, that would have a material adverse effect on our business,
financial condition and results of operations. In addition, our operations and
profitability may be affected by additional legislation, changes in rules
promulgated by the SEC, NASD, the Board of Governors of the Federal Reserve
System, the various stock exchanges and other self-regulatory organizations, and
state securities commissions, or changes in the interpretation or enforcement of
existing laws or rules.
WE ARE RELIANT ON KEY EXECUTIVES, KEY PERSONNEL AND KEY ACCOUNTS.
We believe that our success depends on the efforts and abilities of a
relatively small group of executive personnel. The loss of services of one or
more of these key executives could have a material adverse effect on our
business. We do not maintain key man life insurance on any of our key
executives. We have entered into an employment agreement with Kenneth S.
Shifrin, our Chairman of the Board and Chief Executive Officer, that expires on
April 1, 2007. Additionally, although we have been fortunate in retaining our
key salespersons for many years, a loss of one or more key salespersons and/or a
loss of one or more key accounts is possible and could have a material adverse
effect upon earnings.
WE ARE EXPOSED TO INTEREST RATE RISK.
Our exposure to market risk for changes in interest rates relates to both
our investment portfolio and our revenues generated through commissions at our
financial services segment. All of our marketable fixed income securities are
designated as available for sale and, accordingly, are presented at fair value
on our balance sheets. Fixed rate securities may have their fair market value
adversely affected due to a rise in interest rates, and we may suffer losses in
principal if forced to sell securities that have declined in market value due to
changes in interest rates.
11
Changes in interest rates could have an impact at our broker/dealer
subsidiary, APS Financial. The general level of interest rates may trend higher
or lower in 2006, and this move may impact our level of business in different
fixed-income sectors. If a generally improving economy is the impetus behind
higher rates, then while our investment grade business may drop off, our
high-yield business might improve with improving credit conditions. A volatile
interest rate environment in 2006 could also impact our business as this type of
market condition can lead to investor uncertainty and their corresponding
willingness to commit funds.
As we currently have no debt and do not anticipate the need to take on any
debt in 2006, interest rate changes will have no impact on our financial
position as it pertains to interest expense.
WE ARE EXPOSED TO INVESTMENT RISK.
As of December 31, 2005, our recorded basis in debt and equity securities
was approximately $18.3 million. A material other than temporary decline in the
value of any of these investments could have a material adverse effect on our
financial condition and results of operations.
We regularly review the carrying value of our investments and identify and
record losses when events and circumstances indicate that such declines in the
fair value of such assets below our accounting basis are other than temporary.
During 2004, the value of one of our investments, FIC, had declined
significantly. In October 2004, we determined that this decline in market price
should be considered "other than temporary" as defined in Statements of
Financial Accounting Standards (SFAS) No. 115, Accounting for Certain
Investments in Debt and Equity Securities, as amended. Consequently, we recorded
pre-tax charges to earnings totaling $2,567,000 in 2004. These charges reduced
our cost basis in FIC from $5,647,000, or $14.67 per share, to $3,080,000, or
$8.00 per share which was equal to the quoted market price of FIC shares on
December 31, 2004. During 2005, we took additional pre-tax charges to earnings
totaling $135,000, further reducing our cost basis in FIC to $2,945,000, or
$7.65 per share. While we currently continue to have the ability and the intent
to hold the stock indefinitely, we concluded that the additional uncertainty
created by FIC's late filings, together with the lack of its current financial
information, dictated that the 2004 and 2005 declines should be viewed as other
than temporary. In July, 2005 FIC was able to file its 2003 Form 10-K but has
yet to file any 2004 or 2005 Forms 10-Q or 10-K and thus continues to be
de-listed on the NASDAQ Stock Market.
We also have an investment of 143,000 shares of common stock of
HealthTronics, Inc. Although we have an unrealized gain of approximately
$376,000 as of December 31, 2005, this investment can also be at risk should
market or economic conditions change for the worse or should adverse situations
occur at HealthTronics, such as a major product line becoming obsolete. The
remainder of our corporate equity and fixed income investments share the same
risks as HealthTronics but our exposure is much lower.
FAILURE OF THIRD-PARTY VENDORS TO PROVIDE CRITICAL SERVICES COULD HARM OUR
BUSINESS.
We rely on a number of third parties to assist in the processing of our
transactions, including online and Internet service providers, back office
processing organizations, and market makers. While we have selected these
third-party vendors carefully, we do not control their actions. Any problems
caused by these third parties, including as a result of their not providing us
their services for any reason or their performing their services poorly, could
have a material adverse effect on our business, financial condition and
operating results.
WE ARE SUBJECT TO MARKET FORCES BEYOND OUR CONTROL WHICH COULD IMPACT US
MORE SEVERELY THAN OUR COMPETITORS.
Our securities brokerage business, like other securities firms, is directly
affected by economic and political conditions, broad trends in business and
finance and changes in volume and price levels of securities transactions. In
12
recent years, the U.S. securities markets have experienced significant
volatility. If our trading volume decreases, our revenues decline. Also, when
trading volume is low, our profitability is adversely affected because our
overhead remains relatively fixed, despite lower compensation costs associated
with commission revenues. Severe market fluctuations in the future could have a
material adverse effect on our business, financial condition and operating
results. Although we have diversified our product and service revenue streams,
some of our competitors with more diverse product and service offerings might
withstand such a downturn in the securities industry better than we would.
OUR CUSTOMERS MAY DEFAULT ON THEIR MARGIN ACCOUNTS, EFFECTIVELY PASSING
THEIR LOSSES ON TO US.
Our securities brokerage customers sometimes purchase securities on margin
through our clearing organization; therefore we are subject to risks inherent in
extending credit. This risk is especially great when the market is rapidly
declining. In such a decline, the value of the collateral securing the margin
loans could fall below the amount of a customer's indebtedness. Specific
regulatory guidelines mandate the amount that can be loaned against various
security types. APS Financial rigorously adheres to these guidelines and in a
number of instances exceeds those requirements. Independent of our review, our
corresponding clearing organization independently maintains a credit review of
our customer accounts. If customers fail to honor their commitments, the
clearing organization would sell the securities held as collateral. If the value
of the collateral were insufficient to repay the loan, a loss would occur, which
we may be required to fund. Any such losses could have a material adverse effect
on our business, financial condition and operating results.
APS FINANCIAL MUST MAINTAIN CERTAIN NET CAPITAL REQUIREMENTS THAT COULD
SLOW OUR EXPANSION PLANS OR PREVENT PAYMENTS OF DIVIDENDS.
The SEC, NASD and various other regulatory agencies have stringent rules
with respect to the maintenance of specific levels of net capital by securities
broker-dealers. Net capital is the net worth of a broker or dealer (assets minus
liabilities), less deductions for certain types of assets. If a firm fails to
maintain the required net capital, it may be subject to suspension or revocation
of registration by the SEC and suspension or expulsion by the NASD, and could
ultimately lead to the firm's liquidation. If such net capital rules are changed
or expanded, or if there is an unusually large charge against net capital,
operations that require the intensive use of capital would be limited. Such
operations may include trading activities and the financing of customer account
balances. Also, our ability to pay dividends, repay debt and redeem or purchase
shares of our outstanding stock could be severely restricted. A significant
operating loss or an extraordinary charge against net capital could adversely
affect the ability of APS Financial to expand or even maintain its present
levels of business, which could have a material adverse effect on our business,
financial condition and operating results.
OUR TRADING SYSTEMS MAY FAIL, RESULTING IN SERVICE INTERRUPTIONS.
Our securities brokerage business receives and processes trade orders
through internal trading software and touch-tone telephones and depends heavily
on the integrity of the electronic systems supporting this type of trading.
Heavy stress placed on our systems during peak trading times could cause our
systems to operate too slowly or fail. If our systems or any other systems in
the trading process slow down significantly or fail even for a short time, our
customers would suffer delays in trading, potentially causing substantial losses
and possibly subjecting us to claims for such losses or to litigation claiming
fraud or negligence. During a systems failure, we may be able to take orders by
telephone; however, only associates with securities broker's licenses can accept
telephone orders, and an adequate number of associates may not be available to
take customer calls in the event of a systems failure. In addition, a hardware
or software failure, power or telecommunications interruption or natural
disaster could cause a system failure. Any systems failure that interrupts our
operations could have a material adverse effect on our business, financial
condition and operating results.
13
OUR REVENUES AND OPERATING PERFORMANCE MAY FLUCTUATE WITH INSURANCE
BUSINESS CYCLES.
Growth in premiums written in the medical professional liability industry
have fluctuated significantly over the past 10 years as a result of, among other
factors, changing premium rates. The cyclical pattern of such fluctuation has
been generally consistent with similar patterns for the broader property and
casualty insurance industry, due in part to the participation in the medical
professional liability industry of insurers and reinsurers which also
participate in many other lines of property and casualty insurance and
reinsurance. Historically, the financial performance of the property and
casualty insurance industry has tended to fluctuate in cyclical patterns
characterized by periods of greater competition in pricing and underwriting
terms and conditions, a soft insurance market, followed by period of capital
shortage, lesser competition and increasing premium rates, a hard insurance
market.
For several years in the 1990s, the medical professional liability industry
faced a soft insurance market that generally resulted in lower premium rates.
The medical professional liability industry is currently in a hard insurance
market cycle. We cannot predict whether, or the extent to which, the recent
increase in premium rates will continue.
BECAUSE OUR BOARD OF DIRECTORS MUST BALANCE FIDUCIARY OBLIGATIONS TO APIE
AND TO OUR SHAREHOLDERS, OUR BOARD OF DIRECTORS MAY MAKE DECISIONS THAT ARE NOT
SOLELY IN THE INTERESTS OF OUR SHAREHOLDERS.
As attorney-in-fact, FMI is contractually required to provide management
and administrative services to APIE. In such capacity, FMI also has a fiduciary
duty to the policyholders of APIE to protect their interests. Likewise, we have
a fiduciary duty to our shareholders. Certain issues arise that may create
conflicts of interest between these fiduciary duties. Among such potential
conflicts of interest are:
o Management must devote attention to the business interests of both APIE
and us;
o APIE may enter into other transactions and contractual relationships
with us and our subsidiaries; and
o State regulators could challenge the reasonableness of the transactions
between us and APIE because of potential or actual conflicts of
interest.
As a consequence, our board of directors may make decisions or take actions
that are not solely in the interests of our shareholders, although we believe
that decisions that strengthen APIE could have a long-term positive effect on
us. If, for example, there should be a need to strengthen the surplus of APIE,
our board of directors may decide to reduce the management fee rate and/or that
a capital contribution should be made by us to APIE in the form of a surplus
note or some other form. Under such circumstances, we may be required to provide
such capital to APIE at a lower rate of return than would be available with
other investments or at no return at all. Payments of interest and repayment of
principal on a surplus note are subject to prior approval of the Texas
Department of Insurance, which may not approve such payments. We may also find
it necessary to fund additional surplus for APIE by issuing additional shares of
our capital stock, resulting in dilution of existing shareholders' interest.
IF MARKET CONDITIONS CAUSE REINSURANCE TO BE MORE COSTLY OR UNAVAILABLE FOR
APIE, OUR MANAGEMENT FEE MAY BE REDUCED.
As part of APIE's overall risk management strategy, it purchases
reinsurance for amounts of risk from $250,000 up to $1,000,000. If APIE is
unable to maintain its current reinsurance coverage or to obtain other
reinsurance coverage in adequate amounts and at favorable rates, or if APIE is
unable to renew its expiring reinsurance coverage or to obtain new reinsurance
coverage, APIE may be adversely affected by losses or have to reduce the amount
of risk it underwrites, in either case reducing our management fee.
14
ITEM 2. PROPERTIES
We lease approximately 23,000 square feet of office space from
HealthTronics in an office project at 1301 Capital of Texas Hwy., Suite C-300,
Austin, Texas as our principal executive offices.
We also lease approximately 1,200 square feet of office space for our
financial services subsidiary at 1011 Hwy 6 South, Suite 120, Houston, Texas,
and 7981 168th Ave, N.E. Suite 108, Redmond, Washington.
We also lease approximately 6,000 square feet of office space for our
insurance services subsidiary at 5401 North Central Expressway, Suite 316, LB
#B4, Dallas, Texas.
ITEM 3. LEGAL PROCEEDINGS
We are involved in various claims and legal actions that have arisen in the
ordinary course of our business. We believe that any liabilities arising from
these actions will not have a material adverse effect on our financial condition
or results of operations.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
No matter was submitted during the fourth quarter of the fiscal year
covered by this report to a vote of security holders, through the solicitation
of proxies or otherwise.
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
Our common stock is currently listed on the NASDAQ Small Cap Market under
the symbol "AMPH." The following table sets forth the range of the quarterly
high and low bid prices for the last two fiscal years.
2005 2004
--------------------- -------------------
High Low High Low
---- ---- ---- ----
First Quarter $ 13.24 $ 10.01 $ 14.08 $ 8.31
Second Quarter $ 13.80 $ 9.25 $ 14.92 $ 8.51
Third Quarter $ 13.30 $ 11.50 $ 10.24 $ 8.50
Fourth Quarter $ 13.25 $ 11.37 $ 10.49 $ 9.51
There were approximately 202 holders of record of our common stock on March
1, 2006.
In 2005 and 2004, we declared cash dividends of $0.25 and $0.20,
respectively, per share of common stock amounting to total cash outlays of
approximately $671,000 and $518,000, respectively. Prior to 2004, we had never
declared or paid any cash dividends on our common stock. Our policy has been to
retain our earnings to finance growth and development. The declaration and
payment of any future dividends on our common stock would be at the sole
discretion of our Board of Directors, subject to our financial condition,
capital requirements, future prospects and other factors deemed relevant.
15
The following table represents securities authorized for issuance under
equity compensation plans, as described in Note 12 to the consolidated financial
statements included in Appendix A of this Form 10-K.
Equity Compensation Plan Information
------------------------------------------------------------------------------------------------------------------------------------
Plan Category Number of securities to be Weighted-average exercise Number of securities remaining
issued upon exercise of price of outstanding available for future issuance under
outstanding options, options, warrants equity compensation plans.
warrants and rights. and rights. Excluding securities reflected in
column (a)
------------------------------------------------------------------------------------------------------------------------------------
(a) (b) (c)
------------------------------------------------------------------------------------------------------------------------------------
Equity Compensation
plans approved by 621,000 $7.92 339,000
security holders Note 1 Note 2
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Equity compensation
plans not approved by
security holders none none none
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Total 621,000 $7.92 339,000
------------------------------------------------------------------------------------------------------------------------------------
Note 1: Average price is for the 573,000 shares under the Stock Option Plan
only, as 48,000 shares in the Deferred Compensation Plan are outright grants.
Deferred shares are reflected in the financial statements at the grant date.
Note 2: Shares remaining in the Stock Option Plan is 237,000; shares remaining
in the Deferred Stock Plan is 102,000.
The following table represents stock repurchases during the fourth quarter of
2005:
(d) Maximum
Number of
Shares (or
Approximate
Dollar Value)
(c) Total Number of Shares that
of Shares May Yet be
Purchased as Part Purchased Under
Period (a) Total Number (b) Average of Publicly the Plans or
of shares Price Paid Annonuced Plans Programs
Purchased (1) per Share or Programs
------- --------- ---------- ------------ --------------
Oct. 1, 2005-Oct. 31, 2005 1,450 $ 12.64 1,450 $ 140,000
Nov. 1, 2005-Nov. 30, 2005 9,200 $ 12.55 9,200 $ 25,000
Dec. 1, 2005-Dec. 31, 2005 500 $ 13.06 500 $2,018,000
(1) Of the total shares purchased, 2,950 were purchased in open market
transactions and 8,200 were purchased in private transactions. Our
original $2,000,000 share repurchase program was announced AUgust 17,
2004 and was increased by an additional $2,000,000 on December 12, 2005.
16
ITEM 6. SELECTED FINANCIAL DATA
The following selected financial data should be read in conjunction with
our consolidated financial statements and notes thereto included in Appendix A
of this Form 10-K and "Management's Discussion and Analysis of Financial
Condition and Results of Operations" contained in Item 7 hereof.
2005 2004 2003 2002 2001
--------------- -------------- -------------- ------------ ----------
Selected Income Statement Data:
Revenues $ 33,973 $ 32,021 $ 30,449 $23,077 $20,036
Income from continuing operations
before interest, income taxes,
minority interests and equity in
loss of unconsolidated affiliates 7,812 3,097 4,090 5,554 851
Income from continuing operations 5,460 2,152 2,772 3,156 (1,568)
Net income $ 5,460 $ 2,152 $ 2,799 $ 3,411 $ (578)
Per Share Amounts:
Basic: Income from continuing
operations $ 2.03 $ 0.85 $ 1.26 $ 1.42 $ (0.85)
Net income 2.03 0.85 1.27 1.53 (0.25)
Diluted: Income from continuing
operations 1.86 0.76 1.13 1.35 (0.85)
Net income $ 1.86 $ 0.76 $ 1.14 $ 1.45 $ (0.25)
Diluted weighted average shares
outstanding 2,931 2,838 2,449 2,345 2,343
Cash Dividends $ 0.25 $ 0.20 - - -
Selected Balance Sheet Data:
Total assets $ 33,505 $ 30,443 $ 25,638 $24,981 $21,660
Long-term obligations - 1,133 1,576 2,665 4,489
Total liabilities $ 5,783 $ 6,229 $ 6,532 $ 7,455 $ 8,869
Minority interests 15 1 - 384 124
Total equity $ 27,707 $ 24,213 $ 19,106 $17,142 $12,667
17
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
FORWARD-LOOKING STATEMENTS
Our statements contained in this report that are not purely historical are
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Exchange Act, including statements regarding
our expectations, hopes, intentions or strategies regarding the future. You
should not place undue reliance on forward-looking statements. All
forward-looking statements included in this report are based on information
available to us on the date hereof, and we assume no obligation to update any
such forward-looking statements. It is important to note that our actual results
could differ materially from those in the forward-looking statements. In
addition to any risks and uncertainties specifically identified in the text
surrounding the forward-looking statements, you should consult our reports on
Forms 10-Q and our other filings under the Securities Act of 1933 and the
Exchange Act, for factors that could cause our actual results to differ
materially from those presented.
The forward-looking statements included herein are necessarily based on
various assumptions and estimates and are inherently subject to various risks
and uncertainties, including risks and uncertainties relating to the possible
invalidity of the underlying assumptions and estimates and possible changes or
developments in social, economic, business, industry, market, legal and
regulatory circumstances and conditions and actions taken or omitted to be taken
by third parties, including customers, suppliers, business partners and
competitors and legislative, judicial and other governmental authorities and
officials. Assumptions relating to the foregoing involve judgments with respect
to, among other things, future economic, competitive and market conditions and
future business decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond our control. Any of these assumptions
could be inaccurate and, therefore, there can be no assurance that the
forward-looking statements included in this report will prove to be accurate.
GENERAL
We provide (1) financial services, including brokerage and investment
services to individuals and institutions, and (2) insurance services, including
management and agency services to medical malpractice insurance companies.
FINANCIAL SERVICES. We provide investment and investment advisory services
to institutions and individuals throughout the United States through the
following subsidiaries:
o APS FINANCIAL. APS Financial is a fully licensed broker/dealer that
provides brokerage and investment services primarily to institutional
and high net worth individual clients. APS Financial also provides
portfolio accounting, analysis, and other services to insurance
companies, banks and public funds. We recognize commissions revenue,
and the related compensation expense, on a trade date basis.
o APS CLEARING. APS Clearing trades and clears non-security transactions
in bank debt and trade claims. We recognize commissions revenue, and
the related compensation expense, when the transaction is complete and
fully funded.
o ASSET MANAGEMENT. Asset Management manages fixed income and equity
assets for institutional and individual clients on a fee basis. We
recognize fee revenues monthly based on the amount of funds under
management.
18
Insurance Services. Through Insurance Services we provide management
and agency services to medical malpractice insurance companies through the
following subsidiary:
o FMI. FMI provides management and administrative services to APIE,
a regional insurance exchange that sells medical professional
liability insurance only to its physician subscribers, who pay
annual insurance premiums and surplus contributions to APIE. APIE
is governed by a physician board of directors. Pursuant to a
management agreement and the direction of this board, FMI manages and
operates APIE, including performing policy issuance, claims
investigation and settlement, and all other management and operational
functions. As a management fee, FMI receives a percentage of APIE's
earned premiums and a portion of APIE's profit, subject to a cap based
on premium levels. We recognize revenues for the management fee
portion based on a percentage of earned premium on a monthly basis. We
recognize revenues for the management fee portion based on profit
sharing in the fourth quarter, when it is certain the managed company
will have an annual profit. FMI's assets are not subject to APIE
policyholder claims.
In addition, as of December 31, 2005, we have the following significant
investments accounted for as available-for-sale securities: (1) we own
approximately 143,000 shares of HealthTronics common stock, representing less
than 1% of its outstanding common stock, (2) we own 385,000 shares of FIC,
representing approximately 4% of its outstanding common stock. Our policy is to
account for investments as available-for-sale securities. This requires that we
assess fluctuations in fair value and determine whether these fluctuations are
temporary or "other than temporary" as defined in Statements of Financial
Accounting Standards (SFAS) No. 115, Accounting for Certain Investments in Debt
and Equity Securities. Temporary changes in fair value are recognized as
unrealized gains or losses excluded from earnings and reported in equity as a
component of accumulated other comprehensive income, net of income taxes. Should
a decline in an investment be deemed other than temporary, as was the case with
our investment with FIC in both 2004 and 2005, pre-tax charges to earnings will
be taken in the period in which the impairment is considered to be other than
temporary.
We also have investments totaling $13,246,000 in low risk governmental and
corporate fixed income securities. These securities are carried at fair value
with unrealized gains and losses, net of taxes, reported in equity as a
component of accumulated other comprehensive income. As above, we would
recognize an impairment charge to earnings in the event a decline in fair value
below the cost basis of one of these investments is determined to be other than
temporary.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of our consolidated financial statements requires us to
make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses. On an on-going basis, we evaluate our
estimates, including those related to impairment of assets; bad debts; income
taxes; and contingencies and litigation. We base our estimates on historical
experience and on various other assumptions that we believe to be reasonable
under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities that are not
readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions.
We believe the following critical accounting policies and estimates affect
our more significant judgments and estimates used in the preparation of our
consolidated financial statements. We periodically review the carrying value of
our assets to determine if events and circumstances exist indicating that assets
might be impaired. If facts and circumstances support this possibility of
impairment, our management will prepare undiscounted and discounted cash flow
projections, which require judgments that are both subjective and complex.
Management may also obtain independent valuations.
Our financial services revenues are composed primarily of commissions on
securities trades. Revenues related to securities transactions are recognized on
a trade date basis.
19
Our insurance services revenues are primarily related to management fees
based on the earned premiums of the managed company and include a profit sharing
component, as defined in the management agreement, related to the managed
company's annual earnings. Management fees are recorded, based upon the terms of
the management agreement, in the period the related premiums are earned by the
managed company. The managed company recognizes premiums as earned ratably over
the terms of the related policy. The profit sharing component is recognized in
the fourth quarter when it is certain the managed company will have an annual
profit.
When necessary, we record an allowance for doubtful accounts based on
specifically identified amounts that we believe to be uncollectible. If our
actual collections experience changes, revisions to our allowance may be
required. We have a limited number of customers with individually large amounts
due at any given balance sheet date. Any unanticipated change in one of those
customers' credit standing or rating could have a material affect on our results
of operations in the period in which such changes or events occur. After all
attempts to collect a receivable have failed, the receivable is written off
against the allowance.
The carrying amounts for cash and cash equivalents approximate fair value
because they mature in less than 90 days and do not present unanticipated credit
concerns.
When necessary, we record a valuation allowance to reduce our deferred tax
assets to the amount that is more likely than not to be realized. While we have
considered future taxable income and ongoing prudent and feasible tax planning
strategies in assessing the need for the valuation allowance, in the event we
were to determine that we would be able to realize our deferred tax assets in
the future in excess of its net recorded amount, an adjustment to the deferred
tax asset would increase income in the period the determination was made.
Likewise, should we determine that we would not be able to realize all or part
of our net deferred tax asset in the future, an adjustment to the deferred tax
asset would be charged to income in the period the determination was made.
We account for our equity and fixed income securities as available for
sale. In the event a decline in fair value of an investment occurs, management
may be required to determine if the decline in market value is other than
temporary. Management's assessments as to the nature of a decline in fair value
are based on the quoted market prices at the end of a period, the length of time
an investment's fair value has been in decline and our ability and intent to
hold the investment. If the fair value is less than the carrying value and the
decline is determined to be other than temporary, an appropriate write-down is
recorded against earnings.
RESULTS OF OPERATIONS
OVERVIEW AND BUSINESS OUTLOOK
APS Financial, the broker/dealer division of our financial services
segment, saw strong growth in its investment banking division in 2005 while
commission revenues from security trading mirrored those recorded in 2004. APS
Clearing, which represents a new revenue stream, was formed in 2005 from
commissions earned on the trading and clearing of non-security transactions in
bank debt and trade claims. The investment banking department was ramped up in
2005 with the hiring of a dedicated investment banker who was successful in
closing several private placement transactions. Commission revenues from
investment-grade trading was flat in a soft investment climate, while revenues
from non-investment grade (high-yield) trades saw an increase, particularly in
the latter half of the year.
For commission revenue generation, bullish, unstable markets provide us
with the most opportunity. Conversely, stable, bearish markets pose the greatest
difficulty in generating income. Uncertainty in world, political and economic
events can also be an obstacle to revenue generation. Investors may take a
wait-and-see attitude should uncertainty exist.
Although we have been fortunate in retaining our key salespersons for many
years, a loss of one or more key individuals and/or a loss of one or more key
accounts is possible and could have a material adverse effect upon earnings.
20
The nature of the broker/dealer business and the current litigious legal
environment in which we operate means that there is always the possibility of
one or more lawsuits being brought against us. Claims against broker/dealers
generally rise in periods of down markets and the more prolonged a downturn,
generally the greater risk of litigation.
APS Insurance Services enjoyed a record year in 2005 in revenues. Total
surplus at APIE grew approximately 41% in 2005 compared to 2004. If APIE's
surplus continues to grow, this would continue to increase the financial
strength of the company and its capacity to write new business and therefore
increase the amount of profit in which we would be able to share. For 2006, we
expect non-variable operating expenses to increase over 2005, primarily as a
result of anticipated new personnel hires required to support estimated growth
in new business. Professional fees may be higher or lower depending upon final
resolution by the SEC as to whether or not micro-cap companies are exempt from
compliance with Section 404 of the Sarbanes-Oxley Act of 2002.
Our insurance segment is greatly affected by the profitability of the
medical malpractice insurance company that we manage. Significant increases in
claims brought against our insured doctors would negatively affect the
profitability of APIE, and consequently, the amount of profit, if any, we would
be able to share in. This risk has been reduced by lowering the limits of
liability on the physicians APIE insures coupled with providing policies that
cap our overall exposure. Further, there was passage of tort and insurance
reform in the State of Texas in 2003. The new legislation capped non-economic
damages and placed restrictions on mass litigation. As a result of tort reform,
competitors have begun to re-enter the State of Texas, which could result in
pressure to lower rates or a reduction in the number of insurance policies
written by APIE.
Although consolidated net earnings were up substantially in 2005 compared
to the two previous years, combined net earnings from our two core segments was
down slightly in 2005 compared to 2004. The primary reason for the large
increase in consolidated net earnings is the result of unusually high gains on
the sales of our investments in 2005 and unusually high other-than-temporary
impairments charges of investments recorded in 2004. Such gains and losses are
not likely to be repeated.
There were no off-balance sheet arrangements as of December 31, 2005 and
2004.
2005 COMPARED TO 2004
---------------------
Revenues from operations increased $1,952,000 (6%) in 2005 compared to
2004. Our operating income decreased $499,000 (9%) to $4,845,000 compared to
$5,344,000 in 2004. Our net earnings increased $3,308,000 (154%) in 2005 to a
total of $5,460,000 compared to net earnings of $ $2,152,000 in 2004. Our
diluted earnings per share increased to $1.86 in 2005 compared to $0.76 in 2004.
The reasons for these changes are described below.
FINANCIAL SERVICES
Our financial services revenues increased $1,754,000 (11%) in 2005 compared
to 2004. The increase was mostly due to contributions from our investment
banking and bank debt trading businesses, which were up a combined $1,709,000
from last year. Of this increase, bank debt trading generated revenues of
$1,166,000 in 2005, its first year of operations, with minimal start-up costs.
This increase, combined with commission revenue from secondary market securities
trading, which was up slightly from 2004, made 2005 APS Financial's second best
year in revenues in its twenty-four year history. Our broker/dealer business
derives most of its revenue from trading in the secondary fixed income market,
both in investment and non-investment grade securities. Commission revenue from
our investment grade market segment was lower, as the Federal Reserve raised
21
short-term rates 13 times for a total of 325 basis points since mid 2004. The
short end of the treasury yield curve, in step with Federal Reserve tightening,
traded to higher yields, while the longer end of the curve hovered near
historically low levels, creating a flat to slightly inverted yield curve in
2005. This created an investment environment where customers continued to be
cautious to commit funds in 2005, particularly to longer maturing instruments,
thus negatively impacting trading revenues. The decline in our investment grade
business was offset by increased activity in the high-yield markets. In 2005,
the U.S. high-yield markets, which were generally considered rich the previous
year, began to correct with some volatility, increasing our trading revenues
from this market segment.
Our financial services expense increased $1,725,000 (12%) in 2005 compared
to 2004. Commission expense, which includes commissions from secondary market
trading, as well as placement fees for investment banking and referral fees for
bank debt trading, was up $1,159,000 (12%) as a result of the above-mentioned
increase in commission revenue. Payroll was up $430,000 (31%) in part due to the
hiring of additional personnel in the investment banking and bank debt trading
areas as the firm ramped up these business efforts, and due to an increase in
performance related forgivable loans. Legal and professional expenses increased
$195,000 (115%) from the previous year, principally due to expenses associated
with our efforts to comply with the provisions of the Sarbanes-Oxley Act of
2002. Partially offsetting these increases was a decrease in incentive
compensation expense of $143,000 (13%) in 2005 compared to 2004 as a result of
higher minimum performance thresholds placed upon management in 2005.
INSURANCE SERVICES
Our insurance services revenues from our premium-based insurance management
segment, APS Insurance Services, increased $198,000 (1%) in 2005 compared to
2004. The primary reason for the current year increase was a $364,000 (4%)
increase in management fees, the result of greater insurance premium volumes.
Earned premium increased at APIE by 4% in 2005 compared to 2004 primarily as a
result of new business, which saw an 8% net increase in the number of insured
professionals, and because of strong retention of our existing business in the
current year. In addition, profits shared with APIE grew $78,000 (4%) to
$2,007,000 in 2005 from $1,929,000 in 2004. Consistent with our revenue
recognition policy, this revenue was not recognized until the fourth quarter of
the year after profit-sharing goals were attained. As the certainty of profits
at APIE cannot be fully known until an end-of-year actuarial analysis by
independent actuaries, we cannot predict what, if any, profits will be available
to us until this analysis is complete. Partially offsetting these increases was
a $118,000 (37%) decrease in risk management fee income in 2005 compared to
2004, the result of a lower number of renewals utilizing this service. Also,
pass-through commissions earned by third-party agents decreased $106,000 (2%) in
2005 to $4,376,000 compared to $4,482,000 in 2004, the result of a 6% decline in
written premiums in the current year. Written premiums are down in 2005 compared
to 2004 as a result of lower new business written during the year along with an
average decrease in premium rates of 8.8%. As noted below, commissions paid to
third-party independent agents decreased by an equivalent amount, resulting in
no impact on net earnings.
Insurance services expenses at our insurance management subsidiary
increased $294,000 (3%) in 2005 compared to 2004. The primary reasons for the
current year increase were higher payroll and higher professional fees. Payroll
increased $185,000 (6%) in 2005 as a result of normal merit raises as well as
the addition of two new managerial positions. Professional fees increased
$175,000 (253%) in 2005 compared to 2004 primarily as a result of fees paid in
association with Sarbanes-Oxley Act compliance requirements. In addition,
depreciation increased $61,000 (25%) in 2005 compared to 2004 due to a
significant increase in capital purchases made during the current year necessary
to upgrade our management information and reporting capabilities. Partially
offsetting these increases was a $106,000 (2%) decrease in commissions expense
due to the above-mentioned increase in commissions paid to third party
independent agents.
22
GENERAL AND ADMINISTRATIVE EXPENSES
General and Administrative expenses increased $510,000 (23%) in 2005
compared to 2004. The current year increase was due primarily to a $269,000
(34%) increase in incentive compensation expense in 2005 resulting from
additional contractual bonuses that will be paid on the greater gains from the
sale of a higher number of shares of HealthTronics common stock completed in
2005. In addition, salaries expense increased $148,000 (23%) in 2005 partially
due to a severance payment to a former employee who has since been retained as a
tax consultant coupled with an addition in salaries at the executive level above
the norm in an effort to remain competitive in the marketplace. Professional
fees increased $59,000 (85%) in 2005 compared to 2004 as a result of fees paid
in association with Sarbanes-Oxley Act compliance requirements. Partially
offsetting these increases was a 2005 decrease in legal fees of $39,000 (64%),
the result of lower utilization of legal consulting in 2005 as well as fees paid
in 2004 in association with a Form S-3 filing that were not necessary in 2005.
GAIN ON SALE OF ASSETS
Gain on sale of assets primarily represents the recognition of deferred
income. During 2005, we recognized approximately $513,000 of deferred gain
related to the November 2001 sale and subsequent leaseback of real estate to
Prime Medical (its name prior to the merger with HealthTronics, Inc.) Due to our
continuing involvement in the property, we deferred recognizing approximately
$2,400,000 of the approximately $5,100,000 gain and are recognizing it in
earnings, as a reduction of rent expense, monthly through November 2006. A total
of $422,000 remains to be recognized. In addition, 15% of the gain ($760,000)
related to our then 15% ownership in the purchaser, was deferred. As our
ownership percentage in HealthTronics declines through our sales of
HealthTronics common stock, we recognize these gains proportionately to our
reduction of our interest in that company. During 2005, we recognized $133,000
of these deferred gains, leaving a balance of approximately $47,000 remaining to
be recognized. The increase in 2005 is the result of an increased number of
HealthTronics common stock shares sold compared to 2004.
GAIN ON INVESTMENTS
Gain on investments increased $2,915,000 (1,190%) in 2005 compared to 2004.
The current year increase in primarily due to gains on the sale of a greater
number of shares of HealthTronics common stock compared to 2004. In addition, we
recorded income of $225,000 from an investment in a private company that was
sold during 2005 and in which we had a zero basis. Partially offsetting these
gains was a write-off totaling $160,000 from an investment loan that was given
earlier in 2005. Information provided by the third party loan obligor at the
time of the loan was proven to be less than complete and it was determined in
September, 2005, after the loan was several months in default, that it is
unlikely that we will recover any of the remaining debt owed us. As such, the
balance of the loan was written off.
LOSS ON IMPAIRMENT OF INVESTMENTS
The current year loss was due to a write-down of our investment in FIC
common stock coupled with an impairment of our investment in Toys R Us bonds.
The loss in 2004 represents an impairment in the value of our investment in FIC
common stock. During 2004, the value of our investment in FIC had declined
significantly. In October 2004, we determined that this decline in market price
should be considered "other than temporary" as defined in Statements of
Financial Accounting Standards (SFAS) No. 115, Accounting for Certain
Investments in Debt and Equity Securities, as amended. Consequently, we recorded
pre-tax charges to earnings totaling $2,567,000 in 2004. These charges reduced
our cost basis in FIC from $5,647,000, or $14.67 per share, to $3,080,000, or
$8.00 per share which was equal to the quoted market price of FIC shares on
December 31, 2004. During 2005, we took additional pre-tax charges to earnings
totaling $135,000, further reducing our cost basis in FIC to $2,945,000, or
$7.65 per share. While we currently continue to have the ability and the intent
to hold the stock indefinitely, we concluded that the additional uncertainty
created by FIC's late filings, together with the lack of its current financial
information, dictated that the 2004 and 2005 declines should be viewed as other
than temporary. In July 2005, FIC was able to file its 2003 Form 10-K but has
yet to file any 2004 or 2005 Forms 10-Q or 10-K and thus continues to be
de-listed on the NASDAQ Stock Market.
23
In April 2004, we purchased $300,000 of Toys R Us bonds. In March 2005,
Toys R Us announced a plan of merger with another toy company and a planned
leveraged buyout, which precipitated a drop in the price of the bonds. An
independent analysis indicated that the new debt to be issued in connection with
the leveraged buyout will put the existing bonds in a subordinated position.
Since these bonds have a 2018 maturity, we believe that the impairment is "other
than temporary" during our shorter than expected holding period. Consequently,
we wrote a charge against pre-tax earnings of $57,000 using the quoted price of
the bonds as of June 30, 2005. By December 2005, the value of the bonds had
declined further and, based in part upon weak earnings reports, we determined
that an additional impairment charge of $24,000 was necessary using the quoted
price of the bonds as of December 31, 2005. We will continue to monitor and
evaluate the situations at both FIC and Toys R Us and further determine if
changes in fair market value of these investments are temporary or "other than
temporary."
GAIN ON THE EXTINGUISHMENT OF DEBT
During 2005 and 2004, we recorded $24,000 and $75,000, respectively, as
gains on extinguishment of debt. The 2004 amount represents that amount of
liability that was released by participants in our loan to a former affiliate.
Due to poor operating results, the affiliate was in default and not making
scheduled payments under its loan agreement with us in which the participations
had been sold. As a result, the loan participants released us from any
obligations under the participation agreements. In September 2005, we determined
there is a remote possibility that the final obligation, totaling $24,000, will
be required to be paid under the terms of the participation agreement and as a
result, we reversed it and recognized a gain in the same amount.
INTEREST INCOME
Our interest income increased $222,000 (61%) in 2005 compared to 2004
primarily as a result of a higher balance of interest-bearing securities held in
2005 as well as to higher average interest rates. At December 31, 2005, we held
a balance of $13,246,000 in fixed income securities versus a balance of
$4,903,000 at December 31, 2004. The increase in 2005 was primarily attributable
to cash received upon the sale of equity securities.
OTHER INCOME (LOSS)
Our other income increased $109,000 (727%) in 2005 compared to 2004. The
increase in 2005 was due to net gains in inventory held briefly at APS Financial
in 2005 totaling $26,000 versus net inventory losses of $30,000 in 2004. In
addition, we received $103,000 in administrative fee income from Eco-Systems in
2005 versus $47,000 in 2004 resulting from their increase in earnings in the
current year.
MINORITY INTERESTS
For the years 2005 and 2004, minority interests represents a 3% interest
in Asset Management, a subsidiary within our financial services segment, owned
by key individuals within Asset Management. Minority interests increased in the
current year due to a prior period adjustment resulting from our acquisition of
a former 2% minority interest shareholder.
CASH FLOWS
Our cash flows provided from operations decreased $3,144,000 (58%) in 2005
compared to 2004 due in part to the receipt of $1,050,000 in profit sharing from
APIE in December 2004 with the remainder received in early 2005. None of the
2005 profit sharing was received in 2005. In addition, we paid nearly $1,500,000
more in federal income taxes in 2005 than in 2004, the result of taxes owed on
much larger gains on investments. Our cash flows used in investing activities
decreased $354,000 (8%) in 2005 as a result of lower capital expenditures as
well as increased net receipt of loans over the amount funded. Our cash used in
financing activities increased $887,000 (192%) in 2005 primarily as a result of
24
a $1,000,000 increase in the purchase of our treasury stock compared to 2004.
Partially offsetting this was a $278,000 increase in cash received from the
exercise of stock options.
2004 COMPARED TO 2003
---------------------
Revenues from operations increased $1,572,000 (5%) compared to 2003. Our
operating income increased $1,381,000 (35%) to $5,344,000 in 2004 compared to
$3,963,000 in 2003. Our net earnings decreased $647,000 (23%) in 2004 to a total
of $2,152,000 compared to net earnings of $2,799,000 in 2003. Our diluted
earnings per share decreased to $0.76 in 2004 compared to $1.14 in 2003. The
reasons for these changes are described below.
FINANCIAL SERVICES
Our financial services revenues decreased $2,918,000 (15%) in 2004
compared to 2003. Although commission revenues in 2004 were the second highest
in APS Financial's twenty-three year history, they were down compared to 2003,
which saw record commission revenues at APS Financial. Our broker/dealer derives
most of its revenue from trading in the fixed income market, both in investment
and non-investment grade securities. Revenue from both grade securities was
lower. Investment grade markets are typically linked to treasury rates, which
continued to trade in 2004 at a historically low yield levels. Customers have
been cautious on committing funds, particularly to longer maturing instruments,
thus negatively impacting trading revenues. Also, in 2004 the U.S. high-yield
markets were almost universally considered over-valued, trading at historically
low spreads to treasuries. Again, this contributed to a reluctance of our
customers to commit funds, and contributed to lower revenues.
Our financial services expense decreased $2,046,000 (12%) in 2004 compared
to 2003. The primary reason for the current year decrease is a $1,714,000 (15%)
decrease in commission expense resulting from the decrease in commission revenue
at APS Financial mentioned above. In addition, net profits before management
incentive costs decreased at APS Financial by $1,284,000 (29%) resulting in a
$530,000 (33%) decrease in the current year formula driven incentive
compensation costs. Partially offsetting these decreases was an increase in
payroll costs of $108,000 (8%) in 2004 resulting from normal annual merit raises
as well as the hiring of two new full-time positions. In addition, there were
relatively minor current year increases in employee benefits, professional fees
and information services.
INSURANCE SERVICES
Our insurance services revenues from our premium-based insurance management
segment, APS Insurance Services, increased $4,490,000 (41%) in 2004 compared to
2003. One of the primary reasons for the current year growth is an increase of
$1,207,000 (167%) in profits shared with APIE. The total amount of profit
sharing recognized in 2004 was $1,929,000, all of which was recognized during
the fourth quarter of 2004, after profit sharing goals were attained. In 2003,
we recognized all of that year's total of $722,000 in profit sharing during the
fourth quarter as well. As the certainty of profits at APIE cannot be fully
known until an end-of-year actuarial analysis by independent actuaries, we
cannot predict what, if any, profits will be available to us until this analysis
is complete. Another main reason for the growth in revenues in 2004 was a
$1,607,000 (23%) increase in management fees resulting from greater insurance
premium volumes. Earned premium increased at APIE by 24% in 2004 compared to
2003 primarily as a result of new business and strong retention of our existing
business in the current year. Lastly, commission income increased $1,435,000
(47%) in 2004 compared to 2003, resulting from approximately $15,040,000 in
additional written premium in the current year. As noted below, commissions paid
to third party independent agents increased by an equivalent amount, resulting
in no impact on net income.
Insurance services expenses at our insurance management subsidiary
increased $2,127,000 (27%) in 2004 compared to 2003. The current year increase
25
is primarily due to the $1,435,000 (47%) increase in commissions paid to third
party independent agents. In addition, payroll expense increased $208,000 (8%)
and formula driven incentive compensation expense increased $206,000 (39%) in
2004 compared to 2003. Payroll expense was up in the current year due primarily
to normal annual merit raises in addition to personnel additions made in the
latter half of 2003 that were expensed the entire year in 2004. Among the
additions was a high-level management position to help meet our growing
financial reporting requirements. The increase in formula driven incentive
compensation cost was the result of an increase in segment operating profits.
Excluding incentive compensation costs, pre-tax profits at our insurance segment
rose $2,679,000 (95%). Lastly, depreciation and amortization costs were $102,000
(74%) higher in 2004 compared to 2003 as a result of amortizing the non-compete
agreement that was created upon the repurchase of the 20% minority interest in
October 2003 for a full year compared to only three months in 2003. Partially
offsetting these increases was a $176,000 (79%) decrease in advertising in 2004
compared to 2003, a result of re-branding efforts of the business performed in
2003.
GENERAL AND ADMINISTRATIVE EXPENSES
General and administrative expenses increased $158,000 (8%) in 2004
compared to 2003. The current year increase was primarily due to higher
incentive compensation expense which was $126,000 (19%) greater in 2004 on
substantially higher operating income in the current year. Other professional
fees were $40,000 (136%) higher in 2004 primarily as a result of fees incurred
in connection with Sarbanes-Oxley Act internal control procedures. Also,
director's fees increased $59,000 (64%) as a result of a higher fee structure
implemented in 2004 as well as an increased number of board and committee
meetings compared to 2003. Partially offsetting these increases was a decrease
in legal fees of $29,000 (32%) in 2004, the result of non-recurring fees
incurred in 2003 in connection with our investment in FIC.
GAIN ON SALE OF ASSETS
Gain on sale of assets primarily represents the recognition of deferred
income. Approximately $760,000 of the $5,100,000 deferred gain on the sale of
real estate to Prime Medical (its name prior to the merger with HealthTronics,
Inc.) in 2001 was due to our ownership interest in Prime Medical and is
recognized upon the reduction of our ownership percentage in Prime Medical
through the sale of its stock. In 2004, we recognized approximately $56,000 from
the sale of a higher number of shares of Prime Medical common stock versus 2003,
when a gain of $8,000 was recorded.
GAIN ON INVESTMENTS
Gain on investments increased $118,000 (93%) in 2004 compared to 2003 as a
result of gains from the sale of a greater number of available-for-sale equity
securities sold in the current year.
LOSS FROM IMPAIRMENT OF INVESTMENTS
The current year loss was due to a write-down of our investment in FIC
common stock. During 2004, in accordance with SFAS 115, we determined that the
decline in market value of FIC common stock was other than temporary and we
recorded pre-tax charges to earnings totaling $2,567,000. These charges reduced
our cost basis in FIC from $5,647,000, or $14.67 per share, to $3,080,000, or
$8.00 per share which is equal to the quoted market price of FIC shares on
December 31, 2004. We believe the decline in the market price of FIC has been
brought about by its failure to file its 2003 Form 10-K and its subsequent
de-listing from the NASDAQ Stock Market. We had expected FIC to bring its
filings current and pursue restoring its exchange listing but these events have
not yet occurred. While we currently continue to have the ability and the intent
to hold the stock indefinitely, we have concluded that the additional
uncertainty created by the late filings together with the lack of current
financial information dictates that the decline should be viewed as other than
temporary.
26
AFFILIATES EARNINGS (LOSS)
Our equity in the earnings of Prime Medical (its name prior to the merger
with HealthTronics, Inc.) was zero in 2004 as well as in 2003 as we no longer
account for our investment in Prime Medical using the equity method of
accounting, as was the case in the first quarter of 2002 when we recorded
$186,000 in equity earnings. As of March 19, 2002, we ceased accounting for our
investment in Prime Medical using the equity method of accounting because (1) on
January 1, 2002, Kenneth S. Shifrin, our Chairman and CEO, stepped down from
day-to-day operations as Executive Chairman of the Board of Prime Medical, but
continued to serve as non-executive Chairman. Mr. Shifrin further reduced his
responsibilities on Prime's Board to Vice-Chairman in 2004; and (2) from January
to March 19, 2002, we sold 1,570,000 shares of Prime Medical common stock
reducing our ownership percentage in 2002 to approximately 5%.
Our equity in earnings of Uncommon Care was zero in 2004, $260,000 in 2003
and a loss of $230,000 in 2002. Because our total investment and advances to
Uncommon Care has been reduced to zero, we suspended recording equity losses, as
required under the equity method. In 2002, we advanced them $230,000 and
recorded a loss for the full amount of the advance. In 2003, after informing
Uncommon Care's management that we would make no further advances, we recorded
equity in earnings of unconsolidated affiliates in the amount of $260,000
related to cash received from Uncommon Care. We expect no further receipts of
cash from Uncommon Care and consequently expect to record no additional income
in the future.
INTEREST INCOME
Our interest income increased $61,000 (20%) in 2004 compared to 2003
primarily as a result of a higher balance of interest-bearing securities held in
2004. At December 31, 2004, we had a balance of $4,903,000 in fixed income
securities versus a balance of $897,000 at December 31, 2003.
OTHER INCOME (LOSS )
Our other income increased $53,000 in 2004 as a result of a write-down
taken in 2003 totaling $120,000 on an equity investment. Partially offsetting
this was a decrease of $51,000 in administrative fee income from Eco-Systems in
2004 resulting from their decreased earnings.
MINORITY INTERESTS
Minority interests represents the combination of two outside interests in
our subsidiaries: a 20% interest in Insurance Services owned by FPIC Insurance
Group, Inc. and a 3% interest in APS Asset Management or APSAM, a subsidiary
within our financial services segment, owned by key individuals within APS Asset
Management. Minority interests decreased in the current year due to the
repurchase of the 20% minority interest in Insurance Services from the minority
interest holder, FPIC Insurance Group, effective October 1, 2003. Consequently,
only nine months of minority interest was recorded in 2003 compared to a full
year in 2002. During 2004, minority interest was recorded only at APSAM and
amounted to just $1,000.
DISCONTINUED OPERATIONS
Effective November 1, 2003, APS Consulting paid off the negotiated
remaining amount of the note payable to us. Even though we had sold this segment
to APS Consulting's management exactly one year earlier, we continued to
consolidate their revenues, expenses and balance sheet items because we were
dependent upon future successful operations of the division to collect our
proceeds from the disposal and we did not transfer risk of loss to discontinue
reporting them on our consolidated financial statements. With the payoff of the
note, we recognized the divesture and now report APS Consulting as a
discontinued operation. Accordingly, 2002 has been reclassified to remove
revenues and expenses from our consolidated statements of operations and
after-tax results of this former division are now recorded as income from
discontinued operations in 2002. For 2003, only the after-tax gain on disposal
of the segment is recorded as earnings from APS Consulting. There was no effect
in 2004.
27
CASH FLOWS
For the year ended December 31, 2004 our cash provided by operations
increased $814,000 (17%) compared to 2003 as a result of the increase in
operating income at our insurance services segment. Cash used in investing
activities increased $1,089,000 (33%) in 2004 compared to 2003 as a result of
proceeds from the sale of available-for-sale equity securities during 2003,
which were much greater than those received in 2004. Cash provided by financing
activities decreased $1,339,000 (153%) in 2004 as a result of fewer options
exercised compared to 2003, a greater number of treasury stock shares purchased
during 2004 and cash dividends paid in 2004.
LIQUIDITY AND CAPITAL RESOURCES
WORKING CAPITAL
Our net working capital was $15,880,000 and $10,673,000 at December 31,
2005 and 2004, respectively. The increase in the current year was due primarily
to the purchase of short-term fixed income securities through the sale of
long-term equity securities. In addition, we received $2,313,000 in cash from
operations. Historically, we have maintained a strong working capital position
and, as a result, we have been able to satisfy our operational and capital
expenditure requirements with cash generated from our operating and investing
activities. These same sources of funds have also allowed us to pursue
investment and expansion opportunities consistent with our growth plans.
Although there can be no assurance our operating activities will provide
positive cash flow in 2006, we are optimistic that our working capital
requirements will be met for the foreseeable future for the following reasons:
(1) our current cash position is very strong, with a balance of approximately
$6.7 million comprising 20% of our total assets; (2) our investments in
available-for-sale equity and fixed income securities could provide an
additional $18.3 million should the need arise; and (3) we renewed a line of
credit in April 2005 that is described below.
LINE OF CREDIT
During April 2005, we renewed a $3.0 million line of credit that was
originally established in November 2003 with PlainsCapital Bank. The loan calls
for interest payments only to be made on any amount drawn until April 15, 2006,
when the entire amount of the note, principal and interest then remaining
unpaid, shall be due and payable. At December 31, 2005, there were no draws
taken against this line of credit. We are in compliance with the covenants of
the loan agreement, including requirements for a minimum of $5.0 million of
unencumbered liquidity and a minimum 2 to 1 net worth ratio.
CAPITAL EXPENDITURES
Our capital expenditures for equipment were $307,000 and $421,000 in 2005
and 2004, respectively. Our capital expenditures were higher than normal in 2004
and 2005 due to purchases necessary to upgrade our reporting software at our
insurance services subsidiary. We expect capital expenditures in 2006 to be
approximately $225,000, all of which is expected to be funded through cash on
hand.
COMMITMENTS
There were no participation agreements or purchase commitments at December
31, 2005. We have committed cash outflow related to operating lease arrangements
with a term exceeding one to five years at December 31, 2005, as follows (in
thousands):
28
Payment Due
Contractual Cash Obligation 2006 2007 2008 2009 2010 Total
----------------------------------------------------------------
Operating Leases $278 $164 $34 $5 $0 $481
===== ===== ==== === === =====
MARGIN LOANS
We extend credit to our customers, which is financed through our clearing
organization, Southwest Securities, Inc. or Southwest, to help facilitate
customer securities transactions. This credit, which earns interest income, is
known as "margin lending." In margin transactions, the client pays a portion of
the purchase price of securities, and we make a loan (financed by our clearing
organization) to the client for the balance, collateralized by the securities
purchased or by other securities owned by the client.
In permitting clients to purchase on margin, we are subject to the risk of
a market decline, which could reduce the value of our collateral below the
client's indebtedness. Agreements with margin account clients permit our
clearing organization to liquidate our clients' securities with or without prior
notice in the event of an insufficient amount of margin collateral. Despite
those agreements, our clearing organization may be unable to liquidate clients'
securities for various reasons including the fact that the pledged securities
may not be actively traded, there is an undue concentration of certain
securities pledged, or a trading halt is issued with regard to pledged
securities. If the value of the collateral were insufficient to repay the margin
loan, a loss would occur, which we may be required to fund. As of December 31,
2005, the total of all customer securities pledges on debit balances held in
margin accounts was approximately $2.9 million while the total value of the
securities within these margin accounts was approximately $24.8 million. We are
also exposed should Southwest be unable to fulfill its obligations for
securities transactions.
Our ability to make scheduled payments or to fund planned capital
expenditures will depend on our future performance, which, to a certain extent,
is subject to general economic, financial, competitive, legislative, regulatory
and other factors that are beyond our control. There can be no assurance that
our business will generate cash flow from operations or that we will realize
anticipated revenue growth and operating improvements sufficient to make
scheduled payments and fund planned future capital expenditures.
INFLATION
Our operations are not significantly affected by inflation because we are
not required to make large investments in fixed assets. However, the rate of
inflation will affect certain of our expenses, such as employee compensation and
benefits.
IMPACT OF NEW ACCOUNTING STANDARDS
As more fully described in Note 1 of Notes to consolidated financial
statements, on July 1, 2005, we are required to adopt several new accounting
standards. For a discussion of the impact of those new accounting standards upon
us, see Note 1 (n).
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
We have exposure to changes in interest rates and the market values of our
investments but have no material exposure to fluctuations in foreign currency.
29
INTEREST RATE RISK
Our exposure to market risk for changes in interest rates relates to both
our investment portfolio and our revenues generated through commissions at our
financial services segment. All of our marketable fixed income securities are
designated as available-for-sale and, accordingly, are presented at fair value
on our balance sheets. Fixed rate securities may have their fair market value
adversely affected due to a rise in interest rates, and we may suffer losses in
principal if forced to sell securities that have declined in market value due to
changes in interest rates.
Changes in interest rates could have an impact at our broker/dealer
subsidiary, APS Financial. The general level of interest rates may trend higher
or lower in 2006, and this move may impact our level of business in different
fixed-income sectors. If a generally improving economy is the impetus behind
higher rates, then while our investment grade business may drop off, our
high-yield business might improve with improving credit conditions. A volatile
interest rate environment in 2006 could also impact our business as this type of
market condition can lead to investor uncertainty and their corresponding
willingness to commit funds.
As we currently have no debt and do not anticipate the need to take on
any debt in 2006, interest rate changes will have noimpact on our financial
position as it pertains to interest expense.
INVESTMENT RISK
As of December 31, 2005, our recorded basis in debt and equity securities
was approximately $18.3 million. We regularly review the carrying value of our
investments and identify and record losses when events and circumstances
indicate that such declines in the fair value of such assets below our
accounting basis are other than temporary. During 2004, the value of one of our
investments, FIC, had declined significantly. In October 2004, we determined
that this decline in market price should be considered "other than temporary" as
defined in Statements of Financial Accounting Standards (SFAS) No. 115,
Accounting for Certain Investments in Debt and Equity Securities, as amended.
Consequently, we recorded pre-tax charges to earnings totaling $2,567,000 in
2004. These charges reduced our cost basis in FIC from $5,647,000, or $14.67 per
share, to $3,080,000, or $8.00 per share which was equal to the quoted market
price of FIC shares on December 31, 2004. During 2005, we took additional
pre-tax charges to earnings totaling $135,000, further reducing our cost basis
in FIC to $2,945,000, or $7.65 per share. While we currently continue to have
the ability and the intent to hold the stock indefinitely, we concluded that the
additional uncertainty created by FIC's late filings, together with the lack of
its current financial information, dictated that the 2004 and 2005 declines
should be viewed as other than temporary. In July 2005, FIC was able to file its
2003 Form 10-K but has yet to file any 2004 or 2005 Forms 10-Q or 10-K and thus
continues to be de-listed on the NASDAQ Stock Market.
The effect on our financial statements as a result of these write-downs was as
follows:
2005 2004
---------- --------
Reduction in Pre-tax Earnings $ 135,000 $2,567,000
Reduction in Other Comprehensive Income 89,000 1,694,000
Reduction in Deferred Tax Assets 46,000 873,000
We will continue to monitor and evaluate the situation at FIC and
further determine if changes in fair market value of the investment are
temporary or "other than temporary."
30
We also have an investment of 143,000 shares of common stock of
HealthTronics, Inc. Although we have an unrealized gain of approximately
$376,000 as of December 31, 2005, this investment can also be at risk should
market or economic conditions change for the worse or should adverse situations
occur at HealthTronics, such as a major product line becoming obsolete. The
remainder of our corporate equity and fixed income investments share the same
risks as HealthTronics but our exposure is much lower.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The information required by this Item is contained in Appendix A attached
hereto.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
None.
ITEM 9A. CONTROLS AND PROCEDURES
DISCLOSURE CONTROLS AND PROCEDURES
We maintain controls and other procedures that are designed to ensure that
information required to be disclosed by us in reports that we file or submit
under the Exchange Act is recorded, processed, summarized and reported within
the time periods specified in the SEC's rules and forms. In response to recent
legislation, we implemented changes to our disclosure controls and procedures,
primarily to formalize and document procedures already in place, and to
establish a disclosure committee consisting of some of our officers and other
management.
As of the end of the period covered by this report, and under the
supervision and with the participation of our management, including our Chief
Executive Officer (principal executive officer) and Chief Financial Officer
(principal financial officer), we evaluated the effectiveness of our disclosure
controls and procedures (as defined under Rule 13a-15(e) of the Exchange Act).
Based on this evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures are effective.
We do not expect that our disclosure controls and procedures or our other
internal controls can prevent all error and all fraud or that our evaluation of
these controls and procedures can provide absolute assurance that all control
issues and instances of fraud, if any, have been detected. The benefits of
controls and procedures must be considered relative to their costs, and the
design of any system of controls is based in part upon assumptions about the
likelihood of future events. There can be no assurance that any design will
succeed in achieving its stated goals under all potential future conditions.
Over time, controls and procedures may become inadequate because of changes in
conditions, or the degree of compliance with the policies or procedures may
deteriorate. Because of these and other inherent limitations in controls and
procedures, misstatements or omissions due to error or fraud may occur and not
be detected.
During the last fiscal quarter of 2005, we have not made any changes in our
internal controls or in other factors that could have materially affected, or is
reasonably likely to materially affect, internal controls over our financial
reporting.
ITEM 9B. OTHER INFORMATION
None.
31
PART III
Certain information required by Part III is omitted from this Form 10-K
because we will file a definitive Proxy Statement pursuant to Regulation 14A, or
Proxy Statement, not later than 120 days after the end of the fiscal year
covered by this Form 10-K, and certain information to be included therein is
incorporated herein by reference.
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The information required by this Item is incorporated by reference to the
Proxy Statement under the heading "Directors and Executive Officers of the
Registrant."
ITEM 11. EXECUTIVE COMPENSATION
The information required by this Item is incorporated by reference to the
Proxy Statement under the heading "Information Regarding Executive Officer
Compensation."
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The information required by this Item is incorporated by reference to the
Proxy Statement under the heading "Security Ownership of Certain Beneficial
Owners and Management."
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The information required by this Item is incorporated by reference to the
Proxy Statement under the heading "Certain Relationships and Related
Transactions."
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this Item is incorporated by reference to the
Proxy Statement under the heading "Corporate Governance - Committees of the
Board of Directors - The Audit Committee."
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) 1. Consolidated Financial Statements
The required information is contained in Appendix A attached hereto.
2. Financial Statement Schedule (Schedule II)
3. Exhibits (1)
3.1 Restated Articles of Incorporation of the Company, as amended. (5)
3.2 Amended and Restated Bylaws of the Company. (5)
4.1 Specimen of Common Stock Certificate. (2)
4.2 Rights Agreement, dated as of August 15, 2000, between
American Physicians Service Group, Inc. and American Stock
Transfer & Trust Company, which includes the form of Statement
of Resolutions setting forth the terms of the Junior
32
Participating Preferred Stock, Series A, the form of Rights
Certificate as Exhibit B and the Summary of Rights to Purchase
Preferred Shares as Exhibit C. (10)
*10.1 1995 Incentive and Non-Qualified Stock Option Plan of American
Physicians Service Group, Inc. (6)
*10.2 Form of Stock Option Agreement (ISO). (6)
*10.3 Form of Stock Option Agreement (Non-Qualified). (6)
10.4 Management Agreement of Attorney-in-Fact, dated August 13, 1975,
between FMI and American Physicians Insurance Exchange. (2)
*10.5 Profit Sharing Plan and Trust, effective December 1, 1984, of the
Company. (3)
*10.6 First Amendment to 1995 Incentive and Non-Qualified Stock Option Plan
of American Physicians Service Group, Inc. Dated December 10, 1997.
*10.7 First Amendment to 1995 Non-Employee Director Stock Option Plan of
American Physicians Service Group, Inc. Dated December 10, 1997. (8)
10.8 Contribution and Stock Purchase Agreement dated January 1, 1998
between the Company, Additional Purchasers, Barton Acquisition, Inc.,
Barton House, Ltd., Barton House at Oakwell Farms, Ltd., Uncommon
Care, Inc., George R. Bouchard, John Trevey and Uncommon Partners,
Ltd. (9)
10.9 Loan Agreement dated January 1, 1998 between the Company and Barton
Acquisition, Inc. (9)
10.10 Promissory Note (Line of Credit) dated January 1, 1998 between the
Company and Barton Acquisition, Inc. in the amount of $2,400,000. (9)
10.11 Security Agreement dated January 1, 1998 between the Company and
Barton Acquisition, Inc. (9)
10.12 Participation Agreement dated March 16, 1998 between the Company and
Additional Purchasers referred to as Participants. (9)
10.13 Convertible Promissory Note dated April 27, 1999 between the Company
and Uncommon Care, Inc. (10)
10.14 Replacement Convertible Promissory Note dated September 30, 1999
between the Company and Uncommon Care, Inc. (10)
10.15 Liquidity Promissory Note dated September 30, 1999 between the Company
and Uncommon Care, Inc. (10)
10.16 Replacement Liquidity Note dated October 15, 1999 between the Company
and Uncommon Care, Inc. (10)
10.17 $1.25 million Promissory Note dated June 1, 2000 between the Company
and Uncommon Care, Inc. (11)
10.18 $1.20 million Promissory Note dated June 1, 2000 between the Company
and Uncommon Care, Inc. (11)
10.19 Agreement dated November 22, 2002 transferring and assigning all
capital stock of Eco-Systems from the Company to the purchaser. (13)
*10.20 Amended 1995 Incentive and Non-Qualified Stock Option Plan. (13)
10.21 Executive Employment Agreement between the Company and Kenneth S.
Shifrin. (13)
*10.22 Consulting Agreement between the Company and William A. Searles. (13)
33
*10.23 Executive Employment Agreement between the Company and William H.
Hayes. (13)
10.24 Stock Purchase Agreement dated October 31, 2003 between the Company
and FPIC Insurance Group, Inc. (13)
10.25 Revolving Promissory Note dated April 15, 2004 between the Company and
PlainsCapital Bank. (14)
10.26 Commercial Loan Agreement dated April 15, 2004 between the Company and
PlainsCapital Bank. (14)
10.27 2005 Incentive and Non-Qualified Stock Option Plan. (15)
10.28 American Physician Service Group, Inc. Affiliated Group Deferred
Compensation Master Plan. (15)
21.1 List of subsidiaries of the Company. (16)
23.1 Independent Auditors Consent of BDO Seidman, LLP. (16)
31.1 Certification of Chief Executive Officer Pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. (16)
31.2 Certification of Chief Financial Officer Pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. (16)
32.1 Certification of Chief Executive Officer Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002. (16)
32.2 Certification of Chief Financial Officer Pursuant to Section
906 of the Sarbanes-Oxley Act of 2002. (16)
(*) Executive Compensation plans and arrangements.
(1) The Company is subject to the informational requirements of the Exchange
Act and, in accordance therewith, files reports, proxy statements and
other information with the SEC. Reports, proxy statements and other
information filed by the Company can be inspected and copied at the public
reference facilities maintained by the SEC at 450 Fifth Street, N.W.,
Washington, D.C. 20549, and at the SEC's Regional Offices at Seven World
Trade Center, 13th Floor, New York, New York 10048 and CitiCorp Center,
500 West Madison Street, Suite 1400, Chicago, Illinois 60661-2511.
Copies of such material can be obtained by mail from the Public Reference
Section of the SEC at 450 Fifth Street, N.W., Washington, D.C. 20549,
at prescribed rates. Such reports, proxy statements and other information
concerning the Company are also available for inspection at the offices of
The NASDAQ National Market, Reports Section, and 1735 K STREET, N.W.,
WASHINGTON, D.C. 20006. The SEC maintains a Web site that contains
reports, proxy and information statements and other information
regarding registrants that file electronically with the SEC at
http://www.sec.gov and makes available the same documents through
Disclosure, Inc. at 800-638-8241.
(2) Filed as an Exhibit to the Registration Statement on Form S-1,
Registration No. 2-85321, of the Company, and incorporated herein by
reference.
(3) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 1984 and incorporated herein by reference.
(4) Filed as an Exhibit to the Current Report on Form 8-K of the Company
dated September 5, 1989 and incorporated herein by reference.
(5) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 1990 and incorporated herein by reference.
(6) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 1995 and incorporated herein by reference.
34
(7) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 1996 and incorporated herein by reference.
(8) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 1997 and incorporated herein by reference.
(9) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 1998 and incorporated herein by reference.
(10) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 1999 and incorporated herein by reference.
(11) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 2000 and incorporated herein by reference.
(12) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 2002 and incorporated herein by reference.
(13) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 2003 and incorporated herein by reference.
(14) Filed as an Exhibit to the Annual Report on Form 10-K of the Company for
the year ended December 31, 2004.
(15) Filed as an Exhibit to the Current Report on Form 8-K of the Company dated
June 17, 2005.
(16) Filed herewith.
35
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
AMERICAN PHYSICIANS SERVICE GROUP, INC.
By: /s/ Kenneth S. Shifrin
-----------------------------------------
Kenneth S. Shifrin, Chairman of the Board and Chief Executive
Officer
Date: March 13, 2006
Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.
By: /s/ Kenneth S. Shifrin
--------------------------
Kenneth S. Shifrin
Chairman of the Board and
Chief Executive Officer
(Principal Executive Officer)
Date: March 13, 2006
By: /s/ W. H. Hayes
------------------
W. H. Hayes
Senior Vice President - Finance, Secretary
and Chief Financial Officer
(Principal Financial Officer)
Date: March 13, 2006
By: /s/ Thomas R. Solimine
------------------------
Thomas R. Solimine
Controller
(Principal Accounting Officer)
Date: March 13, 2006
By: /s/ Jackie Majors
---------------------
Jackie Majors, Director
Date: March 13, 2006
36
By: /s/ Lew N. Little, Jr.
-----------------------
Lew N. Little, Jr., Director
Date: March 13, 2006
By: /s/ William A. Searles
-------------------------
William A. Searles, Director
Date: March 13, 2006
By: /s/ Cheryl Williams
--------------------------
Cheryl Williams, Director
Date: March 13, 2006
37
APPENDIX A
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Page
Report of Independent Registered Public Accounting Firm A-2
Consolidated Financial Statements
Consolidated Statements of Operations for the Years
ended December 31, 2005, 2004 and 2003 A-3
Consolidated Balance Sheets as of December 31, 2005
and December 31, 2004 A-5
Consolidated Statements of Cash Flows for the Years
ended December 31, 2005, 2004 and 2003 A-7
Consolidated Statements of Shareholders' Equity and Comprehensive
Income (Loss) for the Years ended December 31, 2005, 2004 and 2003 A-8
Notes to Consolidated Financial Statements A-9
A-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders
American Physicians Services Group, Inc.
Austin, Texas
We have audited the accompanying consolidated balance sheets of American
Physicians Services Group, Inc. as of December 31, 2005 and 2004, and the
related consolidated statements of income, stockholders' equity and
comprehensive income (loss), and cash flows for each of the three years in the
period ended December 31, 2005. We have also audited the schedule listed in the
accompanying index. These financial statements and schedule are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements and schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements and schedule are free of material misstatement. The Company is not
required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audits included consideration of internal
control over financial reporting as a basis for designing audit procedures that
are appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial
reporting. According, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements and schedule, assessing the accounting principles used
and significant estimates made by management, as well as evaluating the overall
financial statements and schedule presentation. We believe that our audits
provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of American Physicians
Services Group, Inc. at December 31, 2005 and 2004, and the results of its
operations and its cash flows for the each of the three years in the period
ended December 31, 2005, in conformity with accounting principles generally
accepted in the United States of America.
Also, in our opinion, the schedule presents fairly, in all material respects,
the information set forth therein.
BDO Seidman, LLP
Houston, Texas
March 2, 2006
A-2
AMERICAN PHYSICIANS SERVICE GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands)
Year Ended December 31,
2005 2004 2003
--------- ---------- ----------
Revenues:
Financial services $18,459 $16,705 $19,623
Insurance services 15,514 15,316 10,826
------- ------- -------
Total revenues 33,973 32,021 30,449
Expenses:
Financial services 16,263 14,538 16,584
Insurance services 10,262 9,968 7,841
General and administrative 2,737 2,227 2,069
Gain on sale of assets (134) (56) (8)
------ ------ ------
Total expenses 29,128 26,677 26,486
------ ------ ------
Operating income 4,845 5,344 3,963
Gain on investments, net (Note 5) 3,160 245 127
Loss on impairment of investments (Note 5) (217) (2,567) --
Gain on extinguishment of debt 24 75 --
------ ------ ------
Income from continuing operations before interest,
income taxes, minority interests and equity in earnings
of unconsolidated affiliates 7,812 3,097 4,090
Interest income 587 365 304
Other income (loss) 124 15 (38)
Interest expense 10 7 7
Income tax expense (Note 10) 3,039 1,317 1,640
Minority interests 14 1 197
Equity in earnings of unconsolidated affiliates (Note 15) -- -- 260
------ ------ ------
Income from continuing operations 5,460 2,152 2,772
Discontinued operations (Note 13):
Gain on disposal of discontinued segment
net of income tax expense of $14 in 2003 -- -- 27
------- ------- -------
Net income $ 5,460 $ 2,152 $ 2,799
======= ======= =======
The accompanying notes are an integral part of these consolidated financial
statements.
A-3
AMERICAN PHYSICIANS SERVICE GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS, continued
(In thousands, except per share amounts)
Year Ended December 31,
2005 2004 2003
------- -------- --------
Net income per common share:
Basic:
Income from continuing operations $ 2.03 $ 0.85 $ 1.26
Discontinued operations -- -- 0.01
------ ------ ------
Net income $ 2.03 $ 0.85 $ 1.27
====== ====== ======
Diluted:
Income from continuing operations $ 1.86 $ 0.76 $ 1.13
Discontinued operations -- -- 0.01
------ ------ ------
Net income $ 1.86 $ 0.76 $ 1.14
====== ====== ======
Basic weighted average shares
outstanding 2,688 2,545 2,207
====== ====== ======
Diluted weighted average shares
outstanding 2,931 2,838 2,449
====== ====== ======
The accompanying notes are an integral part of these consolidated financial
statements.
A-4
AMERICAN PHYSICIANS SERVICE GROUP, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)
December 31,
2005 2004
---------- ----------
ASSETS
Current Assets:
Cash and cash equivalents $6,680 $9,673
Trade receivables, net 42 19
Management fees and other receiveables 3,192 1,815
Notes receivable (Note 3) 599 777
Deposit with clearing organization 501 660
Investment in available-for-sale fixed income
securities - current 9,662 1,983
Federal income tax receivable -- 76
Net deferred income taxes 355 124
Prepaid expenses and other current assets 632 642
-------- --------
Total current assets 21,663 15,769
Notes receivable, less current portion (Note 3) 326 141
Property and equipment, net (Note 6) 687 619
Investment in available-for-sale securities:
Equity 5,017 9,417
Fixed Income 3,584 2,920
Net deferred income tax asset 686 --
Goodwill 1,247 1,247
Other assets 295 330
-------- -------
Total Assets $33,505 $ 30,443
======== =========
The accompanying notes are an integral part of these consolidated financial
statements.
A-5
AMERICAN PHYSICIANS SERVICE GROUP, INC.
CONSOLIDATED BALANCE SHEETS, continued
(In thousands, except share data)
December 31,
2005 2004
---------- ---------
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable - trade $736 $266
Accrued incentive compensation 2,595 2,500
Accrued expenses and other liabilities (Note 7) 1,912 1,842
Deferred gain - current 469 488
Federal income tax payable 71 --
------- -------
Total current liabilities 5,783 5,096
Payable under loan participation agreements -- 24
Deferred income tax liability -- 482
Deferred gain - non-current -- 627
------- -------
Total liabilities 5,783 6,229
Minority interests 15 1
Commitments and contingencies (Note 9)
Shareholders' Equity:
Preferred stock, $1.00 par value, 1,000,000
shares authorized, none issued or outstanding -- --
Common stock, $0.10 par value, shares authorized 20,000,000;
2,784,120 and 2,624,372 issued and outstanding
at 12/31/05 and 12/31/04, respectively (Note 18) 278 265
Additional paid-in capital 8,204 7,919
Retained earnings 18,737 13,948
Accumulated other comprehensive income, net of taxes 488 2,081
------- -------
Total shareholders' equity 27,707 24,213
------- -------
Total Liabilities and Shareholders' Equity $33,505 $30,443
======== ========
The accompanying notes are an integral part of these consolidated financial
statements.
A-6
AMERICAN PHYSICIANS SERVICE GROUP, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) Year Ended December 31,
2005 2004 2003
-------- ---------- ---------
Cash flows from operating activities:
Net Income $ 5,460 $ 2,152 $ 2,799
Adjustments to reconcile net income to cash
provided by (used in) operating activities:
Depreciation and amortization 364 304 206
Extinguishment of debt and other 297 39 164
Common stock awarded 159 231 --
Deferred compensation 150 -- --
Minority interest in consolidated earnings 14 1 197
Undistributed earnings of affiliates -- -- (260)
Loss (gain) on sale of assets (134) (56) (8)
Deferred gain on sale of building (513) (488) (488)
Tax benefit from exercise of stock options 708 589 --
Impairment of investment 217 2,567 --
Gain on investments (3,160) (245) (127)
Provision for bad debt -- 20 (58)
Changes in operating assets and liabilities:
Trade and other receivables (23) (179) (325)
Trading account securities -- 67 66
Income tax receivable (28) 1,602 (996)
Deferred income tax (577) 744 2,511
Management fees & other receivables (1,377) (746) (316)
Prepaid expenses & other assets (81) (74) 207
Receivable from clearing organization 159 -- --
Deferred income -- -- (122)
Trade accounts payable 470 66 (138)
Accrued expenses & other liabilities 208 (1,137) 1,331
------ ------ ------
Net cash provided by operating activities 2,313 5,457 4,643
Cash flows from investing activities:
Capital expenditures (307) (421) (319)
Proceeds from the sale of available-for-sale equity
and fixed income securities 8,503 1,116 4,080
Purchase of available-for-sale equity securities (11,688) (4,405) (5,697)
Purchase of minority interest -- -- (2,050)
Receipts from (advances to) affiliate -- -- 175
Funds loaned to others (810) (620) (155)
Collection of notes receivable 346 20 745
------ ------ ------
Net cash used in investing activities (3,956) (4,310) (3,221)
Cash flows from financing activities:
Exercise of stock options 1,036 758 1,351
Purchase and cancellation of treasury stock (1,715) (703) (285)
Dividends paid (671) (518) --
Distribution to minority interest -- -- (190)
------ ------ ------
Net cash provided by (used in) financing activities (1,350) (463) 876
Net change in cash and cash equivalents $(2,993) $ 684 $ 2,298
Cash and cash equivalents at beginning of year 9,673 8,989 6,691
------- ------- -------
Cash and cash equivalents at end of year $ 6,680 $ 9,673 $ 8,989
======= ======= =======
The accompanying notes are an integral part of these consolidated financial
statements.
A-7
AMERICAN PHYSICIANS SERVICE GROUP, INC.
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME (LOSS)
(In thousands, except per share amounts)
Accumulated
Additional Other Total
Common Paid-In Retained Comprehensive Comprehensive Treasury Shareholders'
Stock Capital Earnings Income Income (loss) Stock Equity
------------------------------------------------------------------------------------------------
Balance December 31, 2002 $ 213 $ 5,584 $ 9,515 $ -- $ 1,830 $ -- $ 17,142
Comprehensive income:
Net income -- -- 2,799 2,799 -- -- 2,799
Other comprehensive income,
net of tax:
Unrealized loss on securities,
net of reclassification
adjustment (Note 21) -- -- -- (2,201) (2,201) -- (2,201)
-------
Comprehensive income -- -- -- 598 -- -- --
====
Treasury stock purchases -- -- -- -- -- (284) (284)
Retired treasury stock (6) (279) -- -- -- 284 --
Stock options exercised 38 1,313 -- -- -- -- 1,351
Tax benefit from exercise of
stock options -- 300 -- -- -- -- 300
------------------------------------------------------------------------------------------------
Balance December 31, 2003 $ 245 $ 6,918 $ 12,314 $ -- $ (371) $ -- $ 19,106
================================================================================================
Comprehensive income:
Net income -- -- 2,152 2,152 -- -- 2,152
Other comprehensive income,
net of tax:
Unrealized gain on securities,
net of reclassification
adjustment (Note 21) -- -- -- 2,452 2,452 -- 2,452
------
Comprehensive income -- -- -- 4,604 -- -- --
======
Treasury stock purchases -- -- -- -- -- (703) (703)
Retired treasury stock (7) (696) -- -- -- 703 --
Stock options exercised 25 733 -- -- -- -- 758
Tax benefit from exercise
of stock options -- 589 -- -- -- -- 589
Dividend paid (per share - $0.20) -- -- (518) -- -- -- (518)
Stock awarded 2 229 -- -- -- -- 231
Forgiveness of Uncommon Care Debt -- 146 -- -- -- -- 146
------------------------------------------------------------------------------------------------
Balance December 31, 2004 $265 $7,919 $13,948 $ -- $2,081 $ -- $24,213
================================================================================================
The accompanying notes are an integral part of these consolidated financial
statements.
A-8
AMERICAN PHYSICIANS SERVICE GROUP, INC.
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME (LOSS)
Continued
(In thousands, except per share amounts)
Accumulated
Additional Other Total
Common Paid-In Retained Comprehensive Comprehensive Treasury Shareholders'
Stock Capital Earnings Income Income (loss) Stock Equity
------------------------------------------------------------------------------------------------
Balance December 31, 2004 $265 $7,919 $13,948 $ -- $2,081 $ -- $24,213
------------------------------------------------------------------------------------------------
Comprehensive income:
Net income -- -- 5,460 5,460 -- -- 5,460
Other comprehensive income,
Unrealized loss on securities,
net of taxes of $821 -- -- -- (1,593) (1,593) -- (1,593)
Comprehensive income -- -- -- 3,867 -- -- --
======
Treasury stock purchases -- -- -- -- -- (1,715) (1,715)
Stock options exercised 25 1,011 -- -- -- -- 1,036
Tax benefit from exercise
of stock options -- 708 -- -- -- -- 708
Dividend paid (per share - $0.25) -- -- (671) -- -- -- (671)
Cancelled treasury stock (14) (1,701) -- -- 1,715 --
Forgiveness of Uncommon Care debt -- (40) -- -- -- -- (40)
Stock awarded 1 158 -- -- -- -- 159
Deferred Compensation 1 149 -- -- -- -- 150
------------------------------------------------------------------------------------------------
Balance December 31, 2005 $278 $8,204 $18,737 -- $488 -- $27,707
================================================================================================
The accompanying notes are an integral part of these consolidated financial
statements.
A-9
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(a) General
We, through our subsidiaries, provide financial services that include
brokerage and asset management services to individuals and
institutions, and insurance services that consist of management
services for a malpractice insurance company. The financial services
business has clients nationally. Insurance management is a service
provided primarily in Texas, but is available to clients nationally.
During the three years presented in the financial statements, financial
services generated 54%, 52% and 64% of total revenues and insurance
services generated 46%, 48% and 36% in 2005, 2004 and 2003,
respectively.
(b) Management's Estimates and Assumptions
The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates.
(c) Principles of Consolidation
The consolidated financial statements include our accounts and the
accounts of our subsidiary companies more than 50% owned. Investments
in affiliated companies and other entities, in which our investment is
less than 50% of the common shares outstanding and where we exert
significant influence over operating and financial policies, are
accounted for using the equity method. Investments in other entities in
which our investment is less than 20%, and in which we do not have the
ability to exercise significant influence over operating and financial
policies, are accounted for using the cost method. In the event that we
retain sufficient risk of loss in a disposed subsidiary to preclude us
from recognizing the transaction as a divestiture, we would continue to
consolidate the subsidiary as an entity in which we have a variable
interest under the guidance of FIN 46R.
We own 100% of our insurance services segment after repurchasing the
20% formerly owned by Florida Physicians Insurance Group, Inc.
("FPIC"), on September 30, 2003 (see Note 14). Before this date, we
recorded minority interest to reflect the 20% of its net income or loss
attributable to the minority shareholder.
All significant intercompany transactions and balances have been
eliminated from the accompanying consolidated financial statements.
(d) Revenue Recognition
Our investment services revenues related to securities transactions are
recognized on a trade date basis. Asset management revenues are
recognized monthly based on the amount of funds under management.
Our insurance services revenues related to management fees are
recognized monthly as a percentage of the earned insurance premiums of
the managed company. The profit sharing component of the management
services agreement is recognized when it is reasonably certain that the
managed company will have an annual profit, generally in the fourth
quarter of each year.
A-10
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
(e) Marketable Securities
Our investments in debt and equity securities are classified in three
categories and accounted for as follows:
Classification Accounting
-------------- ----------
Held-to-maturity Amortized cost
Trading securities Fair value, unrealized gains and losses included
in earnings
Available-for-sale Fair value, unrealized gains and losses excluded
from earnings and reported in equity as a
component of accumulated other comprehensive
income, net of applicable income taxes. Realized
gains and losses are included in earnings.
We have included our marketable securities, held as inventory at our
broker/dealer, in the trading securities category. We have included
investments in marketable securities not held as inventory at our
broker/dealer in the available-for-sale securities category.
We account for our equity and fixed income securities as
available-for-sale. In the event a decline in fair value of an
investment occurs, management may be required to determine if the
decline in market value is other than temporary. Management's
assessments as to the nature of a decline in fair value are based on
the quoted market prices at the end of a period, the length of time an
investment's fair value has been in decline and our ability and intent
to hold the investment. If the fair value is less than the carrying
value and the decline is determined to be other than temporary, an
appropriate write-down is recorded against earnings.
(f) Property and Equipment
Property and equipment is stated at cost net of accumulated
depreciation. Property and equipment is depreciated using the
straight-line method over the estimated useful lives of the respective
assets (3 to 5 years). Leasehold improvements are depreciated using the
straight-line method over the life of the lease or their expected
useful life, whichever is shorter.
(g) Long-Lived Assets
Long-lived assets, principally property and equipment, are reviewed for
impairment whenever events or changes in circumstances indicate that
the carrying amount may not be recoverable. If the sum of the
A-11
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
expected future undiscounted cash flows is less than the carrying
amount of the asset, a loss is recognized if there is a difference
between the fair value and carrying value of the asset.
Investments are evaluated for impairment in the event of a material
change in the underlying business. Such evaluation takes into
consideration our intent and time frame to hold or to dispose of the
investment and takes into consideration available information,
including recent transactions in the stock, expected changes in the
operations or cash flows of the investee, or a combination of these and
other factors. Management's evaluation of our investments resulted in
impairment charges in both 2005 and 2004, as detailed in Note 5 to
these consolidated financial statements.
(h) Goodwill and Other Intangible Assets
Goodwill represents the excess of cost over the fair value of net
assets acquired. We account for goodwill and other intangible assets
according to the Statement of Financial Accounting Standards ("SFAS")
No. 142, "Goodwill and Other Intangible Assets", which addresses
financial accounting and reporting matters for acquired goodwill and
other intangible assets. Under the provision of SFAS No. 142, goodwill
is not amortized, but is evaluated annually for impairment or more
frequently if circumstances indicate that impairment may exist. The
goodwill valuation is largely influenced by projected future cash flows
and, therefore, is significantly impacted by estimates and judgments.
We amortize other identifiable intangible assets on a straight-line
basis over the periods expected to be benefited. The components of
these other intangible assets, recorded in Other Assets in the
accompanying consolidated balance sheets, consist primarily of a
non-compete agreement.
(i) Allowance for Doubtful Accounts
When applicable, we record an allowance for doubtful accounts based on
specifically identified amounts that we believe to be uncollectible. If
our actual collections experience changes, revisions to our allowance
may be required. We have a limited number of customers with
individually large amounts due at any given balance sheet date. Any
unanticipated change in one of those customers' credit standing or
rating could have a material affect on our results of operations in the
period in which such changes or events occur. After all attempts to
collect a receivable have failed, the receivable is written off against
the allowance.
(j) Income Taxes
Income taxes are accounted for under the asset and liability method.
Deferred tax assets and liabilities are recognized for the future tax
consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their
respective tax bases and operating loss and tax credit carryforwards.
Deferred tax assets and liabilities are measured using enacted tax
rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. The
effect on deferred tax assets and liabilities of a change in tax rates
is recognized in income in the period that includes the enactment date.
A valuation allowance is provided for deferred tax assets to the extent
realization is not judged to be more likely than not.
A-12
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
(k) Cash and Cash Equivalents
Cash and cash equivalents include cash and highly liquid investments
with a maturity date at purchase of 90 days or less. We deposit our
cash and cash equivalents with high credit quality institutions.
Periodically such balances may exceed applicable FDIC insurance limits.
Management has assessed the financial condition of these institutions
and believes the possibility of credit loss is minimal.
(l) Notes Receivable
Notes receivable are recorded at cost, less allowances for doubtful
accounts when deemed necessary. Management, considering current
information and events regarding the borrowers' ability to repay their
obligations, considers a note to be impaired when it is probable that
we will be unable to collect all amounts due according to the
contractual terms of the note agreement. When a loan is considered to
be impaired, the amount of the impairment is measured based on the
present value of expected future cash flows discounted at the note's
effective interest rate. Impairment losses are included in the
allowance for doubtful accounts through a charge to bad debt expense.
The present value of the impaired loan will change with the passage of
time and may change because of revised estimates of cash flows or
timing of cash flows. Such value changes are reported as bad debt
expense in the same manner in which impairment initially was
recognized. No interest income is accrued on impaired loans. Cash
receipts on impaired loans are recorded as reductions of the principal
amount.
(m) Stock-Based Compensation
We have adopted the disclosure-only provisions of Statement of
Financial Accounting Standards No. 123, Accounting for Stock-Based
Compensation ("Statement 123"), but apply Accounting Principles Board
Opinion No. 25, Accounting for Stock Issued to Employees, in accounting
for our stock option plans. In 2003 we purchased 15,000 unexpired
options from a grantee. This purchase in effect modified the terms of
the option and, accordingly, we recognized $34,000 of compensation
expense in 2003, as required for a modification of terms under FIN 44.
No other compensation expense from stock-based compensation awards was
recognized in 2005, 2004 and 2003. If we had elected to recognize
compensation expense for options granted based on their fair values at
the grant dates, consistent with Statement 123, net income and earnings
per share would have changed to the pro forma amounts indicated below:
A-13
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
Year Ended December 31,
--------------------------------------------------------
2005 2004 2003
---- ---- ----
Net income, as reported $ 5,460,000 $ 2,152,000 $ 2,799,000
Add: Stock-based employee compensation expense
included in net income, net of tax -- -- $ 22,000
Deduct: Total stock-based employee compensation
expense determined under the fair value based
method for all awards, net of related tax effects $ (421,000) $ (550,000) $ (241,000)
----------- ----------- -----------
Pro forma net income $ 5,039,000 $ 1,602,000 $ 2,580,000
============ ============ ============
Net income per share
Basic - as reported $2.03 $0.85 $1.27
===== ===== =====
Basic - pro forma $1.87 $0.63 $1.17
===== ===== =====
Diluted - as reported $1.86 $0.76 $1.14
===== ===== =====
Diluted - pro forma $1.72 $0.56 $1.05
===== ===== =====
The stock-based employee compensation expense above was determined using the
Black Scholes option- pricing model with the following assumptions:
2005 2004 2003
-------- -------- --------
Risk-free interest rate 4.33% 3.03% 2.44%
Expected holding period 3.6 years 3.8 years 3.8 years
Expected volatility .363 .429 .407
Expected dividend yield 2.15% -0- -0-
(n) Recently Issued Accounting Pronouncements
In December 2004, the FASB issued SFAS 153, Exchanges of Nonmonetary
Assets, an amendment of APB No. 29, Accounting for Nonmonetary
Transactions. SFAS 153 requires exchanges of productive assets to be
accounted for at fair value, rather than at carryover basis, unless (1)
neither the asset received nor the asset surrendered has a fair value
that is determinable within reasonable limits or (2) the transactions
lack commercial substance. SFAS 153 is effective for nonmonetary asset
exchanges occurring in fiscal periods beginning after June 15, 2005.
The Company does not expect the adoption of this standard to have a
material effect on its financial position, results of operations or
cash flows.
In December 2003, the Financial Accounting Standards Board published
FIN No. 46-R, "Consolidation of Variable Interest Entities (revised
December 2003)," superseding FIN 46, and exempting certain entities
from the provisions of FIN 46. Generally, application of FIN 46-R is
required in financial statements of
A-14
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
public entities that have interests in structures commonly referred to
as special-purpose entities for periods ending after December 15, 2003,
and for other types of VIEs for periods ending after March 15, 2004. We
currently do not have any variable interest entities therefore the
adoption of this standard did not have a material effect on our
financial position, results of operations or cash flows.
In December 2004, the Financial Accounting Standards Board issued
Statement of Financial Accounting Standards, or SFAS, No. 123 (revised
2004), "Share-Based Payment". Statement 123(R) will provide investors
and other users of financial statements with more complete and neutral
financial information by requiring that the compensation cost relating
to share-based payment transactions be recognized in financial
statements. That cost will be measured based on the fair value of the
equity or liability instruments used. Statement 123(R) covers a wide
range of share-based compensation arrangements including share options,
restricted share plans, performance-based awards, share appreciation
rights, and employee share purchase plans. Statement 123(R) replaces
FASB Statement No. 123, Accounting for Stock-Based Compensation, and
supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees. Statement 123, as originally issued in 1995, established as
preferable a fair-value-based method of accounting for share-based
payment transactions with employees. However, that Statement permitted
entities the option of continuing to apply the guidance in Opinion 25,
as long as the footnotes to financial statements disclosed what net
income would have been had the preferable fair-value-based method been
used. We are required to apply Statement 123(R) as of the first interim
or annual reporting period that begins after December 15, 2005. We
estimate that our pre-tax expense from applying 123 (R) in 2006 and
2007 will be $109,000 and $2,000 respectively, based on unvested
options at December 31, 2005. We are unable to estimate the expense of
any options that may be issued in 2006 and subsequent years due to the
uncertainties of quantity, stock prices, and all other variables
affecting such an estimate.
(o) Reclassification
Certain reclassifications have been made to amounts presented in 2004
and 2003 to be consistent with the 2005 presentation.
(2) MANAGEMENT FEES AND OTHER RECEIVABLES
Management fees and other receivables consist of the following:
December 31,
2005 2004
---- ----
Management fees receivable $2,723,000 $1,661,000
Accrued interest receivable $ 125,000 $ 67,000
Other receivables $ 344,000 $ 87,000
--------- ---------
$3,192,000 $1,815,000
========== ==========
We earn management fees by providing management services to American
Physicians Insurance Exchange ("APIE") under the direction of APIE's
Board of Directors. APIE is a reciprocal insurance exchange, which is
wholly-owned by its subscriber physicians. Subject to the direction of
APIE's Board, and subject
A-15
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(2) MANAGEMENT FEES AND OTHER RECEIVABLES, Continued
to a management services agreement, FMI sells and issues medical
insurance policies, investigates, settles and defends claims, and
otherwise manages APIE's affairs. The management agreement with FMI
obligates APIE to pay management fees to FMI based on a percentage of
APIE's earned premiums before payment of reinsurance premiums. In
addition, the management agreement provides that any profits, as
defined, of APIE will be shared equally with FMI so long as the total
payment (fees and profit sharing) does not exceed a cap based on
premium levels. Management fees attributable to profit sharing were
$2,007,000, $1,929,000,and $722,000 for the years ended December 31,
2005, 2004 and 2003. We earned total management fees and other related
income of $15,514,000, $15,316,000, and $10,826,000, including expense
reimbursements, principally for our independent agents' commissions, of
$4,376,000, $4,482,000, and $3,373,000 for the years ended December 31,
2005, 2004 and 2003, respectively, related to these agreements.
The summarized financial information for APIE as of and for the year
ended December 31, 2005, 2004 and 2003 is as follows:
2005 2004 2003
---- ---- ----
(unaudited) (unaudited) (unaudited)
------------ ------------ ------------
Invested assets $119,556,000 $106,794,000 $86,547,000
Other assets $25,572,000 $24,358,000 $16,181,000
------------ ------------ -----------
Total Assets $145,128,000 $131,152,000 $102,728,000
============ ============ ============
Current liabilities $115,339,000 $109,914,000 $86,945,000
Surplus $29,789,000 $21,238,000 $15,783,000
------------ ------------ -----------
Total liablilities and surplus $145,128,000 $131,152,000 $102,728,000
============ ============ ============
Total revenue $69,757,000 $69,094,000 $56,009,000
Net income $ 8,705,000 $ 4,296,000 $ 1,299,000
Other receivables in 2005, 2004 and 2003 are primarily from our
brokerage and investment advisory services and are principally
comprised of commissions earned by our brokers for trades in the last
week of December 2005, 2004 and 2003.
A-16
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(3) NOTES RECEIVABLE
Notes receivable consist of the following:
December 31,
2005 2004
---- ----
FemPartners, Inc. (Formerly due from Syntera HealthCare Corporation)
Originally due September 1, 2004, the note has been amended three times
since December 2003. Each amendment has extended the note and modified
the payment terms. The current amendment calls for payments of interest
plus principal of $10,000, quarterly, through 2006. The note is
scheduled to be repaid in full in 2007 in three quarterly payments. The
note contains an acceleration clause in the event that FemPartners
conducts an initial public offering or other public sale. $390,000 $420,000
APS Financial Joint Venture Partner
Unsecured term note, principal and interest, at 8% payable monthly
until maturity on October 15, 2005. This note was written off in 2005
with a total charge at the time of write-off amounting to $160,000. - 0 - 235,000
Alianza
Alianza identifies under-payments from insurance companies to medical
providers and recovers the additional amounts. Our loan is to be repaid
from recovery proceeds, with APS receiving a higher percentage of
proceeds if the advances are not repaid within twelve months. In lieu
of interest, we are to receive 15% of gross recoveries. 301,000 - 0 -
Employees
Loans are periodically made to non-officer employees, primarily as
employment retention inducements. Employee notes receivable at December
31, 2005 consisted of three notes of $73,000, $86,000, and $75,000,
which are being amortized through May 2006, December 2006, and June
2007, respectively, provided the employees remain with us; and a note
for $8,000 due currently.
Employee notes receivable at December 31, 2004 consisted of two notes
of $2,000 and $248,000, which are being amortized through October 31,
2005 and June 30, 2006, respectively, provided the employees remain
with us; a note for $14,000 due currently; and two loans totaling
$13,000 to a key employee for advanced education fees. The latter two
notes are forgivable in the amount of approximately $13,000 on each
January 1st that the employee is employed by the Company beginning in
2001 and continuing through 2005. They are due within 90 days should
the employee terminate employment. 242,000 277,000
------- -------
933,000 932,000
Less current portion and allowance for doubtful accounts of $8,000 and
$14,000 in 2005 and 2004, respectively. (607,000) (791,000)
--------- ---------
Long term portion $326,000 $141,000
======== ========
A-17
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(4) FAIR VALUE OF FINANCIAL INSTRUMENTS
For financial instruments the estimated fair value equals the carrying
value as presented in the consolidated balance sheets. Fair value
estimates, methods, and assumptions are set forth below for our
financial instruments.
Notes Receivable
---------------
The fair value of notes has been determined using discounted cash flows
based on our management's estimate of current interest rates for notes
of similar credit quality. The carrying value of notes receivable
approximates their fair value.
Deposit with Clearing Organization
----------------------------------
The carrying amounts approximate fair value because the funds can be
withdrawn on demand and there is no unanticipated credit concern.
Limitations
------------
Fair value estimates are made at a specific point in time, based on
relevant market information and information about the financial
instrument. Fair value estimates are based on existing financial
instruments without attempting to estimate the value of anticipated
future business and the value of assets and liabilities that are not
considered financial instruments. In addition, the tax ramifications
related to the realization of the unrealized gains and losses can have
a significant effect on fair value estimates and have not been
considered in the aforementioned estimates.
(5) MARKETABLE SECURITIES
The following table summarizes by major security type the cost, fair
market value, and unrealized gains and losses of the investments that
we have classified as available-for-sale:
Gross Gross
Unrealized Unrealized Fair
Cost Gains Losses Value
---------------------------------------------------------------
December 31, 2005
Governmental obligations $12,418,000 $ 12,000 $ (60,000) $12,370,000
Corporate obligations 888,000 1,000 (13,000) 876,000
Equity securities 4,217,000 800,000 -- 5,017,000
----------- --------- -------- ----------
Total $17,523,000 $ 813,000 $ (73,000) $18,263,000
=========== ========= ========== ===========
December 31, 2004
Governmental obligations $ 3,492,000 $ -- $ (26,000) $ 3,466,000
Corporate obligations 1,406,000 51,000 (20,000) 1,437,000
Equity securities 6,268,000 3,149,000 -- 9,417,000
----------- ---------- --------- ----------
Total $11,166,000 $3,200,000 $ (46,000) $14,320,000
=========== ========== ========== ===========
A-18
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(5) MARKETABLE SECURITIES, continued
Amounts reflected in the table above (page A-18) include equity
securities of HealthTronics with a fair value of $1,095,000 and
$5,900,000 and corporate obligations of HealthTronics with a fair value
of zero and $944,000 at December 31, 2005 and 2004, respectively. At
December 31, 2005 and 2004, amounts also include equity securities of
Financial Industries Corporation ("FIC") with a fair value of
$3,196,000 and $3,080,000, respectively.
Maturities of fixed income securities were as follows at December 31,
2005:
Fair
Cost Value
--------- ----------
Due within one year $ 9,689,000 $ 9,662,000
Due after one year 3,617,000 3,584,000
---------- ---------
Total $13,306,000 $13,246,000
=========== ===========
HealthTronics is the largest provider of lithotripsy (a non-invasive
method of treating kidney stones) services in the United States and is
an international supplier of specialty vehicles for the transport of
high technology medical, broadcast/communications and homeland security
equipment. Through selling of shares since our initial investment of
3,540,000 shares in 1989, our holdings of common stock at December 31,
2005 stood at 143,000, or less than 1% of the common stock outstanding.
We account for HealthTronics as an available-for-sale equity security
and record changes in its value, net of tax, in our balance sheet as
part of "accumulated other comprehensive income."
Financial Industries Corporation ("FIC") is a holding company primarily
engaged in the life insurance business through ownership of several
life insurance companies. In June 2003, we purchased from FIC and the
Roy F. and Joann Mitte Foundation, 339,879 shares of FIC's common stock
as an investment. Earlier in 2003 we had purchased 45,121 FIC shares in
the open market. The 385,000 shares represented an approximate
$5,647,000, which was all sourced from our cash reserves. During 2004,
the value of our investment in FIC had declined significantly. In
October 2004, we determined that this decline in market price was
"other than temporary" as defined in Statements of Financial Accounting
Standards (SFAS) No. 115, Accounting for Certain Investments in Debt
and Equity Securities, as amended. Consequently, we recorded pretax
charges to earnings totaling $2,567,000 in 2004. These charges reduced
our cost basis in FIC from $5,647,000, or $14.67 per share, to
$3,080,000, or $8.00 per share which was equal to the quoted market
price of FIC shares on December 31, 2004. During 2005, we took
additional pretax charges to earnings totaling $135,000, further
reducing our cost basis in FIC to $2,945,000, or $7.65 per share.
While we currently continue to have the ability and the intent to
hold the stock indefinitely, we concluded that the additional
uncertainty created by FIC's late filings, together with the lack of
its current financial information, dictated that the 2004 and 2005
declines should be viewed as other than temporary. In July, 2005 FIC
was able to file its 2003 Form 10-K but has yet to file any 2004 or
2005 Forms 10-Q or 10-K and thus continues to be de-listed on the
NASDAQ Stock Market.
A-19
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(5) MARKETABLE SECURITIES, continued
We will continue to monitor and evaluate the situation at FIC and
further determine if changes in fair market value of the investment are
temporary or "other than temporary".
The following table summarizes our recognized gains and losses on
investments. Costs on assets sold were determined on the basis of
specific identification.
Year ended December 31,
2005 2004 2003
---- ---- ----
Proceeds from sales $ 8,503,000 $ 1,116,000 $ 4,080,000
Gain on investments, net 3,160,000 245,000 127,000
Loss on impairment of
investments (217,000) (2,567,000) --
----------- ----------- ----------
Net gains (losses) $ 2,943,000 $(2,322,000) $ 127,000
=========== ============ ==========
(6) PROPERTY AND EQUIPMENT
Property and equipment consists of the following:
December 31,
------------------------------------------
2005 2004
---- ----
Equipment $ 1,289,000 $ 1,150,000
Furniture 647,000 628,000
Software 783,000 643,000
Leasehold improvements 332,000 332,000
-------- --------
$ 3,051,000 $ 2,753,000
Accumulated depreciation $(2,364,000) $(2,134,000)
------------ ------------
$ 687,000 $ 619,000
============ ============
Property and equipment are stated at cost. Depreciation expense of
$239,000, $181,000 and $173,000 in 2005, 2004 and 2003, respectively,
is computed principally on the straight-line method over the estimated
useful lives of the assets. The useful lives for equipment ranges from
three to five years, furniture ranges from five to seven years,
software is depreciated over three years, and leasehold improvements
are depreciated over the life of the lease or their expected useful
life, whichever is shorter.
A-20
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(7) ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities consist of the following as of
December 31:
2005 2004
---- ----
Commissions payable $ 1,258,000 $ 1,260,000
Taxes payable 219,000 205,000
401(k) plan matching 208,000 169,000
Vacation payable 161,000 153,000
Other 66,000 55,000
---------- ---------
$ 1,912,000 $ 1,842,000
=========== ===========
(8) DEFERRED GAIN
In November 2001 we sold all of the remaining 46,000 square feet of
condominium space we owned in an office project located in Austin,
Texas to our former affiliate, HealthTronics. In conjunction with the
sale we leased back approximately 23,000 square feet that housed our
operations prior to the sale. Gain on the sale amounted to
approximately $5.1 million, of which $1.9 million was recognized in
2001 and the balance of gain was deferred. Deferred income of
approximately $2.4 million related to our continuing involvement in 50%
of the useable space was recorded and is being recognized monthly over
the five-year lease term through September 2006. Income recognition
related to this deferral was $512,692 in 2005, and $488,000 in 2004 and
2003. In addition, 15% of the gain ($0.76 million) related to our then
15% ownership in the purchaser was deferred as we accounted for
HealthTronics using the equity method of accounting through the year
ended December 31, 2001. We reduced our investment in HealthTronics and
subsequently recognized a proportionate percentage of the deferred
gain, amounting to $133,000, $56,000 and $8,000 in 2005, 2004, and
2003, respectively. Recognition of the deferred gain is recorded as a
reduction of rent expense in operating expenses in the accompanying
financial statements.
(9) COMMITMENTS AND CONTINGENCIES
Rental expenses under all operating leases were $1,133,000, $1,098,000,
and $997,000, for the years ended December 31, 2005, 2004 and 2003,
respectively. Future minimum payments for leases that extend for more
than one year through 2010 were $278,000; $164,000; $34,000; $5,000, $0
for 2006, 2007, 2008, 2009 and 2010, respectively.
We are involved in various claims and legal actions that have arisen in
the ordinary course of business. Management believes that any
liabilities arising from these actions will not have a significant
adverse effect on our consolidated financial condition or results of
operations.
A-21
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(10) INCOME TAXES
Income tax expense consists of the following:
Year Ended December 31,
2005 2004 2003
---- ---- ----
Continuing Operations:
Federal
Current $ 2,577,000 $ 1,049,000 $ (978,000)
Tax benefit of stock options 708,000 589,000 --
Deferred (446,000) (505,000) 2,511,000
State-Current 200,000 184,000 107,000
--------- --------- ---------
Total from Continuing Operations 3,039,000 1,317,000 1,640,000
Discontinued Operations -- -- 14,000
--------- --------- ---------
$3,039,000 $1,317,000 $1,654,000
========= ========= =========
A reconciliation of expected income tax expense computed by applying
the United States federal statutory income tax rate of 34% to earnings
from continuing operations before income taxes to tax expense from
continuing operations in the accompanying consolidated statements of
operations follows:
Year Ended December 31,
2005 2004 2003
---- ---- ----
Expected federal income tax expense from
continuing operations $2,889,000 $1,179,000 $1,500,000
State taxes 132,000 121,000 72,000
Minority interest -- -- 67,000
Other, net 18,000 17,000 1,000
---------- ---------- ----------
$3,039,000 $1,317,000 $1,640,000
========== ========== ==========
The tax effect of temporary differences that gives rise to significant
portions of deferred tax assets and deferred tax liabilities at
December 31, 2005 and 2004 are presented below:
A-22
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
Year Ended December 31,
--------------------------------
2005 2004
---- ----
Current deferred tax assets (liabilities):
Accrued expenses $ 334,000 $ 113,000
Allowance for doubtful accounts 21,000 11,000
--------- ---------
Total current deferred tax asset 355,000 124,000
========= =========
Non-current deferred tax assets (liabilities):
Write-off of investment in excess of tax loss 946,000 873,000
Other investments -- 8,000
Sales/Leaseback deferred income 159,000 378,000
Investment in available-for-sale securities (175,000) (677,000)
Market value allowance on investments (251,000) (1,072,000)
Other 168,000 136,000
Tax depreciation in excess of book (161,000) (128,000)
--------- ---------
Total non-current net deferred tax liability 686,000 (482,000)
========= =========
Net deferred tax asset (liability) $ 1,041,000 $(358,000)
========= =========
In assessing the realizability of deferred tax assets, management
considers whether it is more likely than not that some portion or all
of the deferred tax assets will not be realized. The ultimate
realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which those temporary
differences become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income,
and tax planning strategies in making this assessment. Based upon the
level of historical taxable income and projections for future taxable
income over the periods that the deferred tax assets are deductible,
management believes it is more likely than not that we will realize the
benefits of these deductible differences at December 31, 2005.
(11) EMPLOYEE BENEFIT PLANS
We have an employee benefit plan qualifying under Section 401(k) of the
Internal Revenue Code for all eligible employees. Employees become
eligible upon meeting certain service and age requirements. Employee
deferrals may not exceed $14,000 in 2005 unless participant is over age
50, in which case the maximum deferral is $18,000. We may, at our
discretion, contribute up to 200% of the employees' deferred amount.
For the years ended December 31, 2005, 2004 and 2003 our contributions
aggregated $208,000, $170,000 and $176,000, respectively.
In December 2004, the Board of Directors approved the "American
Physicians Service Group, Inc. Affiliate Group Deferred Compensation
Master Plan" ("Deferred Compensation Plan"), a non-qualified
compensation plan designed to give us more flexibility in compensating
key employees and directors through ownership of our common stock. The
adoption of the Deferred Compensation Plan was approved by our
shareholders at the 2005 Annual Meeting. Under the Deferred
Compensation Plan we may elect to
A-23
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(11) EMPLOYEE BENEFIT PLANS, continued
defer a portion of an employee's incentive compensation or director's
board compensation in the form of a deferred stock grant. Shares become
eligible for withdrawal with the passage of time and participants may
withdraw eligible shares upon attaining the age of sixty or upon
leaving our service. Plan participants may withdraw all shares granted
to them ratably over four years, provided they have entered into a
non-competition agreement with us. We plan for this to be an unfunded
plan. Shares to be withdrawn will be purchased in the open market or
issued from the authorized shares. In 2005, a total of 21,108 shares
were awarded, for which we recorded an expense of $252,000.
(12) STOCK OPTIONS
We have adopted, with shareholder approval, the "2005 Incentive and
Non-Qualified Stock Option Plan" ("Incentive Plan"). The Incentive Plan
provides for the issuance of up to 350,000 shares of common stock to
our directors and key employees. A total of 113,000 of these options
have been granted as of December 31, 2005, all of which are
exercisable. Simultaneously with shareholder approval of the Incentive
Plan, we cancelled the 149,000 shares not granted under the "1995
Incentive and Non-Qualified Stock Option Plan" ("the 1995 Plan"). Under
the 1995 Plan 460,000 options remain unexercised, of which 370,000 are
exercisable at December 31, 2005.
The exercise price for each non-qualified option share is determined by
the Compensation Committee of the Board of Directors ("the Committee").
The exercise price of a qualified incentive stock option has to be at
least 100% of the fair market value of such shares on the date of grant
of the option. Under the Plans, option grants are limited to a maximum
of ten-year terms; however, the Committee has issued all currently
outstanding grants with five-year terms. The Committee also determines
vesting for each option grant and substantially all outstanding options
vest in two or three approximately equal annual installments beginning
one year from the date of grant.
Presented below is a summary of the stock options held by our employees
and our directors and the related transactions for the years ended
December 31, 2005, 2004 and 2003.
Years Ended December 31,
---------------------------- --------------------------- --------------------------
2005 2004 2003
---------------------------- ---------------------------- --------------------------
Weighted Weighted Weighted
Average Average Average
Exercise Exercise Exercise
Shares Price Shares Price Shares Price
---------- ---------- ---------- ---------- ----------- ----------
Balance at January 1 721,000 $ 6.04 815,000 $ 4.49 939,000 $ 3.51
Options granted 113,000 11.60 146,000 9.93 330,000 6.46
Options exercised (251,000) 4.13 (240,000) 3.16 (378,000) 3.57
Options repurchased -- -- -- -- (15,000) 4.29
Options forfeited/expired (10,000) 9.10 -- -- (61,000) 5.73
--------- ----- --------- -------- --------- ------
Balance at December 31 573,000 $7.92 721,000 $6.04 815,000 $4.49
========= ===== ========= ======== ========= ======
Options exercisable 483,000 $7.96 389,000 $5.80 289,000 $3.01
========= ===== ========= ======== ========= ======
A-24
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(12) STOCK OPTIONS, continued
The weighted average fair value (the theoretical option value
calculated using the Black Scholes option pricing model) of Company
stock options granted is $3.19, $3.58 and $2.20 per option during the
years ended December 31, 2005, 2004 and 2003, respectively. In this
case, as of December 31, 2005, the weighted average theoretical option
value per share of Company stock options ($14.79) less the weighted
average exercise price of options granted ($11.60) equals the weighted
average fair value of options granted ($3.19).
The following table summarizes the Company's options outstanding and
exercisable options at December 31, 2005:
Stock Options Outstanding Stock Options Exercisable
------------------------------------------ ------------------------------
Average Weighted Weighted
Remaining Average Average
Range of Contractual Exercise Exercise
Exercise Prices Shares Life Price Shares Price
--------------- -------- ---------- ---------- -------- ----------
$2.50 to $9.00 209,000 1.6 years $4.00 179,000 $3.95
$9.01 to $11.95 364,000 3.8 years $10.17 304,000 $10.31
-------- --------
Total 573,000 483,000
======== ========
(13) DISCONTINUED OPERATIONS
Effective November 1, 2002, we completed the sale of APS Consulting to
its management as we determined the division's operations were not
consistent with our long-term strategic plan. We sold all of our APS
Consulting shares for a de minimus amount of cash plus a $250,000
seven-year term note at the prime rate plus 3%. Our existing contract,
which was entered into October 1, 2002, provides administrative
support services to APS Consulting for a period of approximately seven
years, and remained in effect. Fees under this contract are dependent
on APS Consulting's pre-tax earnings but may not be less than $200,000
or more than $518,000 over the life of the agreement. Because we were
dependent upon the future successful operation of the division to
collect our proceeds from the disposal and because we had a security
interest in the assets of the division, we had retained a sufficient
risk of loss to preclude us from recognizing the divestiture of APS
Consulting under the guidance of FASB Interpretation No 46.
Accordingly, we did not recognize the divestiture of APS Consulting
and continued to consolidate the division as an entity in which we
have a variable interest that will absorb the majority of the entity's
operating losses if they occurred.
Effective November 1, 2003, APS Consulting was able to obtain third
party financing and repay their note payable to us in exchange for our
agreeing to discount the note by $35,000. We provided no guarantees or
credit enhancements in connection with APS Consulting securing this
financing. Accordingly, we no longer have a risk of loss related to
these operations and have recognized the transaction as a divestiture.
As a result, we ceased consolidation of APS Consulting financial
statements effective November 1, 2003. In addition, we were able to
recognize a gain of $27,000, net of tax, and administrative support
fees totaling $84,000 for the period from November 1, 2002 through
October 31, 2003 that had previously been eliminated as intercompany
revenues.
A-25
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(13) DISCONTINUED OPERATIONS, continued
The accompanying financial statements reflect the financial position,
results of operations and cash flows of APS Consulting as discontinued
operations.
(14) REPURCHASE OF MINORITY INTEREST
On October 1, 2003 we purchased for $2,050,000 cash the 20% interest in
APS Insurances Services, Inc., which was owned by FPIC Insurance Group,
Inc. ("FPIC"). We believe the acquisition provided us more control over
operating decisions and improved our earnings and return on capital
with minimal risk. As a result of this transaction, we now own a 100%
interest in APS Insurance Services. Prior to our repurchase of the
minority interest, we consolidated the assets, liabilities and
operations of APS Insurance Services and recorded 20% of its after tax
net income as minority interest. As a part of the purchase agreement we
maintained an agreement with FPIC that limits them from competing with
us in Texas through February 2007. The Company has assigned a value of
$410,000 to this non-compete agreement based on a determination by an
outside consulting firm. The agreement is being amortized on the
straight-line method through its expiration in 2007.
The total cost of the acquisition was $2,050,000 and was allocated to
the 20% interest acquired in APS Insurance Services based on the fair
values of its net assets on the date of acquisition, in accordance with
the purchase method of accounting for business combinations.
A summary of the purchase price allocation for this transaction is as
follows:
Purchase price of 20% interest $2,050,000
Basis of recorded minority interest (393,000)
Allocated to non-competition agreement (410,000)
----------
Excess of purchase price over
assets acquired (goodwill) $1,247,000
==========
Other intangible assets as of December 31, 2005 and 2004, subject to
amortization expense, contains the following:
Gross Carrying Accumulated
For the year ended December 31, 2005 Amount Amortization Net
------------------------------------ -------------------- ------------------ -----------------
Non-compete $ 410,000 $ 270,000 $ 140,000
Managing general agent license 160,000 38,000 122,000
-------------------- ------------------ -----------------
Total 570,000 308,000 262,000
==================== ================== =================
For the year ended December 31, 2004
Non-compete $ 410,000 $ 149,000 $ 261,000
Managing general agent license 160,000 34,000 126,000
-------------------- ------------------ -----------------
Total 570,000 183,000 387,000
==================== ================== =================
A-26
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(14) REPURCHASE OF MINORITY INTEREST, continued
We assume no residual value and estimate annual amortization expense
over the remaining life of the non-compete agreement to be as follows:
Year Amount
---- -------
2006 120,000
2007 20,000
The unaudited pro forma income statement data below for the year ended
December 31, 2003 show the impact of the repurchase as if it had
happened prior to the reporting periods:
2003
Revenue: ------------
As reported $30,449,000
Pro forma $30,449,000
Net earnings as reported $2,799,000
Add: Minority Interest attributable
to APS Insurance Services,
net of income taxes $ 197,000
----------
Pro forma net earnings $ 2,996,000
===========
Earnings per share:
Basic - as reported $1.27
======
Basic - pro forma $1.36
======
Diluted - as reported $1.14
======
Diluted - pro forma $1.22
======
A-27
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(15) Investment in Unconsolidated Affiliates
For the year ended December 31, 2005, 2004 and 2003, respectively, our
equity in the earnings of unconsolidated affiliates consisted of the
following:
December 31,
-------------------
2005 2004 2003
---- ---- ----
Prime Medical Services, Inc. $ -- $ -- $ --
Uncommon Care -- -- $ 260,000
-------- -------- ----------
Earnings $ -- $ -- $ 260,000
======== ======== ==========
On October 12, 1989, we purchased 3,540,000 shares (42%) of the common
stock of Prime Medical. In the ensuing years, the sale of stock, stock
exchanges and stock issuances reduced our ownership and at December 31,
2005 our holdings stood at 143,000 or less than 1% of the common stock
outstanding.
In connection with the sales of Prime Medical (or HealthTronics as of
2004) shares during the year, we recognized gains of $3,020,000 in
2005, $245,000 in 2004, and $64,000 in 2003. The gains are classified
as "Gain on Sale of Investments" in the accompanying consolidated
financial statements. Changes in market value of our HealthTronics
shares are included in shareholders' equity as "accumulated other
comprehensive income."
HealthTronics is an SEC registrant and additional information on the
company can be found on the SEC's web site at www.sec.gov.
On January 1, 1998 we invested approximately $2,078,000 in the
convertible preferred stock of Uncommon Care, Inc. and extended notes
totaling $4,430,000. Uncommon Care is a developer and operator of
Alzheimer's care facilities. We accounted for Uncommon Care using the
equity method.
Recording our share of Uncommon Care's accumulated losses had reduced
the carrying value of our investment and our notes to zero by December
31, 2002. Following Uncommon Care's payment default to its senior
lender in 2003 we sold our interest for a de minimus amount and wrote
off the notes.
Some of our officers and directors participated in the $2,400,000 line
of credit to Uncommon Care. For financial purposes this participation
has been treated as a secured borrowing. In the aggregate, these
officers and directors contributed approximately $259,000 to fund a
10.8% interest in the loan. They participate in the loan under the same
terms as the Company.
We recorded $24,000 and $75,000 in 2005 and 2004, respectively, as gain
on forgiveness of debt. These gains represent that amount of liability
that was released in the respective periods by participants in our loan
to a former affiliate, net of any interest due them fro prior period
payments made by that affiliate. Due to poor operating results,
Uncommon Care was in default and not making scheduled payments under
its loan agreement with us in which the participations had been sold.
As a result, the loan participants released us from any obligations
under thee participation agreements. The $24,000 recorded in 2005
represents the final loan obligation to be released.
A-28
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(15) INVESTMENT IN UNCONSOLIDATED AFFILIATES, continued
During 2003 we decided not to extend any future cash advances to
Uncommon Care. Consequently, we took into income cash payments
previously received from Uncommon Care. Total cash receipts recorded as
equity in earnings of unconsolidated affiliates was $260,000 in 2003.
(16) SEGMENT INFORMATION
Our segments are distinct by type of service provided. Each segment has
its own management team and separate financial reporting. Our Chief
Executive Officer allocates resources and provides overall management
based on the segments' financial results.
Our financial services segment includes brokerage and asset management
services to individuals and institutions.
Our insurance services segment includes financial management for an
insurance company that provides professional liability insurance to
doctors.
Corporate is the parent company and derives its income from interest,
investments and dividends paid by the other segments.
Income from the discontinued consulting segment was derived from
operations in 2002 and from gains on disposal in 2003.
A-29
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
2005 2004 2003
---- ---- ----
Operating Revenues
Financial services $ 18,459,000 $ 16,705,000 $ 19,623,000
Insurance services 15,514,000 15,316,000 10,826,000
Other 1,600,000 4,760,000 2,567,000
---------- ---------- -----------
$ 35,573,000 $ 36,781,000 $ 33,016,000
=========== ============ ============
Reconciliation to Consolidated Statements of Operations:
Total segment revenues 35,573,000 36,781,000 33,016,000
Less: intercompany dividends (1,600,000) (4,760,000) (2,567,000)
----------- ----------- -----------
Total Revenues $ 33,973,000 $ 32,021,000 $ 30,449,000
=========== ============ ============
Operating Income (Loss):
Financial services 2,196,000 2,167,000 3,039,000
Insurance services 5,252,000 5,348,000 2,985,000
Other (1,003,000) 2,589,000 506,000
---------- ----------- -------
$ 6,445,000 $ 10,104,000 $ 6,530,000
=========== ============ ===========
Reconciliation to Consolidated Statements of Operations:
Total segment operating profit $ 6,445,000 $ 10,104,000 $ 6,530,000
Less: intercompany dividends (1,600,000) (4,760,000) (2,567,000)
---------- ----------- ----------
Operating income 4,845,000 5,344,000 3,963,000
Gain (loss) on investments 2,943,000 (2,322,000) 127,000
Gain on extinguishment of debt 24,000 75,000 --
---------- --------- ---------
Income from continuing operations before interest, income taxes,
minority interests and equity in gain
and loss of unconsolidated affiliates 7,812,000 3,097,000 4,090,000
Interest income 587,000 365,000 304,000
Other income 124,000 15,000 (38,000)
Interest expense 10,000 7,000 7,000
Income tax expense 3,039,000 1,317,000 1,640,000
Minority interests 14,000 1,000 197,000
Equity in profit (loss) of affiliates -- -- 260,000
--------- --------- --------
Income from continuing operations 5,460,000 2,152,000 2,772,000
Gain on disposal of discontinued operations,
net of income tax -- -- 27,000
---------- ---------- ----------
Net income $ 5,460,000 $ 2,152,000 $ 2,799,000
=========== ============ ===========
A-30
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(16) SEGMENT INFORMATION, continued
2005 2004 2003
---- ---- ----
Identifiable assets:
Financial services $ 6,061,000 $ 5,106,000 $ 4,970,000
Insurance services:
Intangible assets 1,387,000 1,507,000 1,627,000
Other 5,033,000 4,526,000 3,965,000
Corporate:
Investment in available for sale securities 18,263,000 14,320,000 9,626,000
Other 2,761,000 4,984,000 5,450,000
---------- ---------- ---------
$ 33,505,000 $ 30,443,000 $ 25,638,000
============ ============= ============
Capital expenditures:
Financial services $ 47,000 $ 10,000 $ 32,000
Insurance Services 187,000 362,000 160,000
Corporate 73,000 49,000 31,000
Discontinued Operations - - 96,000
------- ------- -------
$ 307,000 $ 421,000 $ 319,000
========= ========== =========
Depreciation/amortization expenses:
Financial services $ 28,000 $ 27,000 $ 31,000
Insurance Services 274,000 217,000 110,000
Corporate 62,000 60,000 65,000
Discontinued Operations - - -
------- -------- -------
$ 364,000 $ 304,000 $ 206,000
========= ========= =========
During the years ended December 31, 2005, 2004 and 2003, a single
customer represented 46% ($15,514,000), 48% ($15,316,000) and 36%
($10,826,000) of our consolidated revenues.
At December 31, 2005, 2004 and 2003 we had long-term contracts with
that customer and were therefore not vulnerable to the risk of a
near-term severe impact from a reasonably possible loss of the revenue.
However, should that customer default or be unable to satisfy its
contractual obligations, there would be a material adverse effect on
our financial condition and results of operations.
Operating income (loss) is operating revenues less related expenses and
is all derived from domestic operations. Identifiable assets are those
assets that are used in the operations of each business segment (after
elimination of investments in other segments). Corporate assets consist
primarily of cash and cash equivalents, notes receivable, investments
in available-for-sale securities, investments in affiliates and
intangible assets.
A-31
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(17) NET INCOME PER SHARE
Basic income per share are based on the weighted average shares
outstanding without any dilutive effects considered. Diluted earnings
per share reflects dilution from all contingently issuable shares,
including options. A reconciliation of income and average shares
outstanding used in the calculation of basic and diluted earnings per
share from continuing and discontinued operations follows:
For the Year Ended December 31, 2005
----------------------------------------------------
Income Shares Per-Share
(Numerator) (Denominator) Amount
-----------------------------------------------------
Income from continuing operations $ 5,460,000
Basic EPS:
Income available to common stockholders 5,460,000 2,688,000 $2.03
=====
Effect of dilutive securities -- 243,000
--------- ----------
Diluted EPS:
Income available to common stockholders $ 5,460,000 2,931,000 $1.86
========== ========== =====
For the Year Ended December 31, 2004
----------------------------------------------------
Income Shares Per-Share
(Numerator) (Denominator) Amount
-----------------------------------------------------
Income from continuing operations $ 2,152,000
Basic EPS:
Income available to common stockholders 2,152,000 2,545,000 $0.85
=====
Effect of dilutive securities -- 293,000
--------- ----------
Diluted EPS:
Income available to common stockholders $ 2,152,000 2,838,000 $0.76
========== ========== =====
For the Year Ended December 31, 2003
------------------------------------------------------
Income Shares Per-Share
(Numerator) (Denominator) Amount
------------------------------------------------------
Income from continuing operations $ 2,772,000
Discontinued operations, net of tax 27,000
Basic EPS:
Income available to common stockholders 2,799,000 2,207,000 $1.27
=====
Effect of dilutive securities -- 242,000
--------- ----------
Diluted EPS:
Income available to common stockholders $ 2,799,000 2,449,000 $1.14
========== ========== =====
A-32
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(18) SHAREHOLDERS' EQUITY
The following table presents changes in shares outstanding for the
period from December 31, 2003 to December 31, 2005:
Common
Shares Treasury
Outstanding Stock
------------- ---------
Balance December 31, 2002 2,133,843 --
Options excercised 377,800 --
Treasury stock purchases -- 56,976
Treasury stock retirements (56,976) (56,976)
--------- --------
Balance December 31, 2003 2,454,667 --
========= ========
Options excercised 240,200 --
Treasury stock purchases -- 70,495
Treasury stock retirements (70,495) (70,495)
--------- --------
Balance December 31, 2004 2,624,372 --
========= ========
Options excercised 251,000 --
Deferred compensation 47,855 --
Treasury stock purchases -- 139,107
Treasury stock retirements (139,107) (139,107)
--------- --------
Balance December 31, 2005 2,784,120 --
========= ========
(19) SUPPLEMENTAL CONSOLIDATED QUARTERLY FINANCIAL DATA (UNAUDITED)
Quarter to quarter comparisons of results of operations have been and
may be materially impacted by bond market conditions and whether or
not there are profits at the medical malpractice insurance company
which we manage and whose profits we share. We believe that the
historical pattern of quarterly sales and income as a percentage of
the annual total may not be indicative of the pattern in future years.
The following tables set forth selected quarterly consolidated
financial information for the years ended December 31, 2005, 2004 and
2003:
A-33
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(In thousands, except per share data)
2005 First Second Third Fourth
Quarter Quarter Quarter Quarter
------- ------- -------- --------
Revenues $ 6,662 $ 7,033 $ 9,182 $ 11,096
Net Income 853 1,367 1,395 1,845
Basic net income per share: $ 0.32 $ 0.51 $ 0.52 $ 0.67
Diluted income per share: $ 0.30 $ 0.48 $ 0.48 $ 0.64
2004
Revenues $ 7,290 $ 7,295 $ 7,593 $ 9,843
Net Income 694 689 (834) 1,603
Basic net income per share: $ 0.28 $ 0.28 $ (0.32) $ 0.62
Diluted income per share: $ 0.25 $ 0.25 $ (0.32) $ 0.58
Results for the fourth quarter of 2005, 2004 and 2003 include profit
sharing with APIE totaling $2,007,000, $1,929,000 and $722,000,
respectively.
Certain amounts previously classified as cost of revenues at Insurance
Services have been classified as general and administrative in the
consolidated statements of income for the years ended 2004 and 2003.
For the year ended December 31, 2004 the amount of reclassifications
totaled $590,000. For the year ended December 31, 2003 the amount of
reclassifications totaled $741,000.
(20) CONCENTRATION OF CREDIT RISK
Marketable securities
---------------------
As of December 31, 2005 we owned marketable securities of HealthTronics
and Financial Industries Corporation with a combined fair market value
of $4,291,000, or approximately 13% of our total assets. An event
having a material adverse effect on HealthTronics and/or Financial
Industries, and resulting in a devaluation of their securities could
also have a material adverse effect on our results of operations.
Geographic concentration of insurance services
----------------------------------------------
Most of the managed insurance company's business is concentrated in
Texas. Regulatory or judicial actions in that state that affected
rates, competition, or tort law could have a significant impact on the
insurance company's business. Consequently, our insurance management
business, which is based on the premiums and profitability of the
managed company, could be adversely affected.
Financial market concentration of investment services
-----------------------------------------------------
Investment Services derives most of its revenue through commissions
earned on the trading of fixed-income securities. Should conditions
reduce the market's demand for fixed-income products, and should
Investment Services be unable to shift it emphasis to other financial
products, it could have a material adverse impact on our financial
condition and results of operations.
A-34
AMERICAN PHYSICIANS SERVICE GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2005, 2004 and 2003
(21) OTHER COMPREHENSIVE INCOME
The following chart discloses the reclassification adjustments for
gains and losses included in net income during the years ended December
31:
Tax
Before-Tax (Expense) Net-of-Tax
Amount or Benefit Amount
2005 -------- ---------- ----------
----
Unrealized holding gains
arising during the period $254 ($87) $167
Reclassification adjustment for gains
included in net income (2,667) 907 (1,760)
-------- ------- -------
Net unrealized losses on securities ($2,413) $820 ($1,593)
======== ======= =======
2004
----
Unrealized holding gains
arising during the period $1,393 ($474) $919
Reclassification adjustment for losses
included in net income 2,322 (789) 1,533
-------- ------- -------
Net unrealized gains on securities $3,715 ($1,263) $2,452
======== ======= =======
2003
----
Unrealized holding losses
arising during the period ($3,246) $1,104 ($2,142)
Reclassification adjustment for gains
included in net income (89) 30 (59)
-------- ------- --------
Net unrealized losses on securities ($3,335) $1,134 ($2,201)
======== ======= ========
A-35
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
American Physicians Service Group, Inc. and Subsidiaries
Years Ended December 31, 2005, 2004 and 2003
(in thousands)
Balance at Balance
Beginning Costs and at End
of Year Expenses Deductions of Year
------------------------------------------------------------
Allowance for Doubtful Accounts
2005 $ 14 $ - $ 6 $ 8
============== ============= ============== =============
2004 $ - $ 47 $ 33 $ 14
============== ============= ============== =============
2003 $ 64 $ 15 $ 79 $ -
============== ============= ============== =============
A-36